Next Article in Journal
A Transcriptomic Meta-Analysis Shows Lipid Metabolism Dysregulation as an Early Pathological Mechanism in the Spinal Cord of SOD1 Mice
Next Article in Special Issue
Targeting of Telomeric Repeat-Containing RNA G-Quadruplexes: From Screening to Biophysical and Biological Characterization of a New Hit Compound
Previous Article in Journal
The Role of Somatic Mutations on the Immune Response of the Tumor Microenvironment in Prostate Cancer
Previous Article in Special Issue
Exploring the Interaction of Curaxin CBL0137 with G-Quadruplex DNA Oligomers
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Non-Canonical Helical Structure of Nucleic Acids Containing Base-Modified Nucleotides

1
Department of Chemistry, Gyeongsang National University, Jinju 52828, Gyeongnam, Korea
2
The Research Institute of Natural Science, Gyeongsang National University, Jinju 52828, Gyeongnam, Korea
3
Department of Chemistry Education, Gyeongsang National University, Jinju 52828, Gyeongnam, Korea
*
Authors to whom correspondence should be addressed.
These authors contributed equally to this review.
Int. J. Mol. Sci. 2021, 22(17), 9552; https://doi.org/10.3390/ijms22179552
Submission received: 2 August 2021 / Revised: 27 August 2021 / Accepted: 29 August 2021 / Published: 2 September 2021

Abstract

:
Chemically modified nucleobases are thought to be important for therapeutic purposes as well as diagnosing genetic diseases and have been widely involved in research fields such as molecular biology and biochemical studies. Many artificially modified nucleobases, such as methyl, halogen, and aryl modifications of purines at the C8 position and pyrimidines at the C5 position, are widely studied for their biological functions. DNA containing these modified nucleobases can form non-canonical helical structures such as Z-DNA, G-quadruplex, i-motif, and triplex. This review summarizes the synthesis of chemically modified nucleotides: (i) methylation, bromination, and arylation of purine at the C8 position and (ii) methylation, bromination, and arylation of pyrimidine at the C5 position. Additionally, we introduce the non-canonical structures of nucleic acids containing these modifications.

1. Introduction

In recent years, research on chemical alterations in nucleobases has increased as it is used for therapeutic purposes and the diagnosis of genetic diseases [1,2,3]. These nucleic acid bases can be naturally modified or chemically synthesized. In particular, many artificially modified nucleobases are widely used with methyl, halogen, and aryl groups of purine at the C8 position [3,4,5,6] and pyrimidine at the C5 position [7,8,9] (Figure 1). Despite the numerous studies conducted on this topic, most of the properties and functions of base-modified substituents have not yet been fully determined. There have been comprehensive studies and reviews investigating the synthetic methods used and structural studies of the artificial alteration of nucleobases.
The two ordinary purines—adenine and guanine—can undergo a conformational equilibrium between the anti and syn conformations. It is generally accepted that the sterically large substituent at the C8 position of the purine nucleotide shows a preferential structure for the syn glycoside conformation [6,10,11]. The typical conformation of the DNA duplex is that B-DNA forms an anti-conformation preferred by the DNA bases of A-T and G-C under physiological conditions [12]. Interestingly, solvents, agents, and chemical modifications promote non-B conformations of DNA, such as Z-DNA [13,14,15] and G-quadruplex (G4) [16,17,18]. This interesting fact about non-canonical structural sequences is correlated with disease-inducing genes and plays a vital role in biological functions. For instance, Z-DNA-forming sequences are identified near transcription initiation sites [19,20].
Base modifications play a pivotal role in forming alternative structures from DNA and RNA. The modifications at the C8 position of purines are used to study Z-DNA and G-quadruplex as potent secondary structure inducers [21]. Interestingly, chemical modifications of DNA base or naturally modified DNA lead to other alternative structures in DNA such as H-DNA and triplex helix formation [22]. On the other hand, the C8- modifications of RNA are supported to form Z-RNA and RNA-quadruplex structures from locally known RNA structures [23]. Since C5 methylation of tRNA sequence changes base pairing to Levitt base pairs instead of Watson–Crick base pairs, the methylated guanosine at the C5 position interferes with the role of tRNA and forms RNA duplexes.
Despite the numerous studies conducted in this field, the roles and conformational properties of non-canonical DNA structures, including syn conformations, are not yet fully understood. Typically, non-canonical structures form under certain conditions: (i) higher-salt conditions favor Z-DNA; (ii) guanine-rich sequences form the tetraplex of G4. Thus, it is necessary to mimic or induce alternative conditions for further investigation. This review discusses the synthesis of chemically modified nucleotides and oligo-nucleotides containing modified bases and their effects on the non-canonical structures [24].

2. Synthesis of C8-Modified Purine

Several purine modifications have been observed in DNA. Most purine modifications are correlated with DNA mutations, such as oxidation, methylation, and nitration. The purine modification mainly focuses on the C8 position. Over the past 40 years, numerous modifications have been synthesized, such as methylated purine, brominated purine, and arylated purines at the C8 position [25,26,27,28,29]. These modified purines show potential for biological analysis and the investigation of the secondary structures of DNA [30,31,32]. This section describes various alterations of guanosine, including some introductions of adenosine.

2.1. Synthesis of C8-Methylpurine

DNA methylation is the addition of a methyl group to a nucleic acid base, and it will occur naturally in the cell or the methylation caused by endogenous and exogenous electrophiles [33]. A single methylation can change the role of a particular DNA segment without altering other sequences. Moreover, methylation is an essential mechanism for normal development and has been implicated in biological activities such as the repression of gene transcription, genomic imprinting, and carcinogenesis [33,34,35]. The chemically modified purine at the C8 position possesses therapeutics activity like 8-methyl guanosine induced to release the tumor necrosis factor α (TNF-α) [36]. The various chemicals of methylated purine bases have been used by different methods and positions of methylation in DNA [37,38,39]. Several nucleophilic sites of DNA, such as guanine at the N3 and C8 positions and adenine at the N1, N3, and C8 positions, have been used for producing various types of methyl purines [37].
An efficient method for C8-methylation in guanine, adenine, hypoxanthine, and its derivatives is a metal ion mediated radical reaction that generates the radical in an acidic medium to form methylated nucleosides [39,40,41]. A free radical methylation method was introduced using t-butyl hydroperoxide (TBHP) as a source of methylation catalyzed by ferrous ions [42]. Methylation of guanosine and its derivatives has been found to give good yields in acidic conditions due to the influence of C8 carbon on the electronic properties of 2,6-substituents on a purine nucleoside ring [39,42,43,44,45,46]. Figure 2a shows a general methylation reaction scheme for guanosine. Naturally formed methylated nucleic acid derivatives were investigated using deuterium labeling with methylated nucleoside [33]. An electron-impact fragmentation pattern showed that guanine is more advantageous for obtaining structural information from mass spectroscopy than those of adenine or hypoxanthine due to high reactivity. Similarly, a detailed analysis of the C8-methyl substitution reaction of guanine reported by Eistetter and coworkers concluded that N-7 and N-9 substitution also occur during the methylation isolated products from the reaction [47].
8-methylated adenosine was successfully formed by a palladium-catalyzed cross-coupling reaction of 8-bromoadenosine, as shown in Figure 2b [46,48,49]. This cross-coupling reaction made it applicable to incorporate an alkyl group into various nucleosides for further biochemical studies.

2.2. Synthesis of C8-Bromopurine

The brominated purine nucleosides at the C8 position are capable of inducing high-level proliferation of lymphocytes in the presence or absence of a serum condition [50]. 8-bromoadenosine acts as a very selective ligand for the A3 adenosine receptor subtype, behaving as an adenosine antagonist [51]. Brominated adenosine derivatives at the C8 position induce a delayed chain termination in vitro and have been proven to moderate HIV activity in cell culture [52,53].
Over the past few years, various reagents have been employed for the direct bromination or insertion of bromine at the C8 position of purine analogs. There are two types of modifications: the direct bromination of the C8 position of purine monomer and post-DNA synthesis modification [54,55]. Figure 3 shows the reaction scheme of guanosine and adenosine with N-bromosuccinamide (NBS) for direct bromination at the C8 position [56,57,58].

2.3. Synthesis of C8-Arylpurine

The formation of new carbon–carbon bonds is particularly important in nucleoside modifications caused by transition metal-catalyzed cross-coupling reactions. These cross-coupling reactions are important for the synthesis of an agro-chemical, organic compound, and pharmaceutical. Cross-coupling reactions have been used in the synthesis of biaryl and heteroaryl compounds, including purines arylated by nucleophilic substitution or metal-mediated reactions [59,60,61,62]. 8-arylated purines have been used as the antivirus activators, anti-Parkinson agents, and adenosine receptor antagonists [63,64]. In addition, 8-arylated purines are widely used as a marker in the structural analysis of nucleic acids, therapeutic agents, and epigenetics [65,66,67].
As shown in Figure 4, the direct arylation at the C8 position in purines is caused by the metal-mediated cross-coupling reactions, which use unprotected halogenated nucleosides as a starting material. The cross-coupling reactions in water-soluble reagents are cost-effective and eliminate the additional steps, such as deprotecting the protective functional groups in nucleosides [68,69,70,71].
Furthermore, the cross-coupling reaction conditions and yields of the product depend on various water-soluble phosphine ligands. For example, tripheylphosphine trisulfonate (TPPTS) and Tris(2,4-dimethyl-5-sulfophenyl) phosphine trisodium salt (TXPTS) are more effective phosphine ligands. Comparing ligands activities, TXPTS was reported to have a higher-level conversion rate of product (~99%) in a 17-hrs conservation time scale than TPPTS (70%). Despite the C8-arylated nucleotide conversion rate depending on halogenated nucleobases, 8-BrdG has a lower conversion rate of development than 8-BrdA. There are also other factors involved in the conversion of C8-aryl nucleotides. For example, at low pH, the N-7 coordination of guanine with palladium (II) is favored, whereas, at the higher pH, the N-1 coordination is preferred.
The recent development of the direct arylation of DNA sequences has some advantages over compared to the arylation of monomers. This method is known as post-synthesis modification. Site-specific modification is carried out by replacing halogenation, such as Br or I with desired aryl groups [72].
Moreover, the post-synthesis of DNA modification in a guanine-base methodology has been developed [72]. Direct C-H arylation was performed using the cross-coupling, which was reported as the first-time feasibility of a cross-coupling reaction for the synthesis of C8-arylated guanine-modified oligonucleotides. Natural fungal carcinogens were used as substrates for cross-coupling reactions. Excellent yields up to 15 mer can be modified with this protocol.
Another exciting C8 modification is the addition of an oxidative group at the C8 position of purine and the synthesis of the 8-oxo dG [73]. The 8-oxo purines are also used to study non-canonical structures, such as C8-aryl purines. The sequence of an oxidative form of the 8-oxo dG is recognized by formamidopyrimidine-DNA (Fpg protein) [74]. Various research groups recently developed efficient methods for synthesizing C8-aryl purines by direct arylation [62,75,76,77,78]. Table 1 summarizes the different functionalized C8-aryl purines syntheses from various purine derivatives (Figure 5).

3. Non-Canonical Structure Containing C8-Modified Guanosine

Modified nucleosides at the C8 position have been incorporated into oligonucleotides to unveil the structural characteristics and biological significances [5,7,21,79]. This section reviews the major contributions of nucleoside alterations to the investigation of Z-DNA and G-quadruplexes.

3.1. Z-DNA

Z-DNA forms a left-handed helix where the base pair is located almost perpendicular to the phosphate backbone, while B-DNA represents a right-handed helical structure. Significant factors influencing the B-Z transition have been identified, such as alternating (CG)n sequences, high salt concentrations, multivalent cations or polycations, and Z binding proteins [14,80,81,82,83]. In addition, steric effects are also important. Since bulky substituents at the C8 position induce a syn conformation with a Z-DNA structure, several base modifications at the C8 position, including 8-methylation, -bromination, and -arylation, have been studied in connection with the B-Z transition [5,6]. Oligomers containing chemically modified nucleotides can remarkably stabilize the Z-form of DNA. These modified oligomers were used to investigate the Z-form binding proteins, the most extensively favorable sequence for Z-form study used as CG repeat sequences. Still, some recent studies show that the d(TA)n sequence can be without purine-pyrimidine repeats and also form Z-DNA and interact with ADAR1 protein. The Zα domain of the ADAR1 protein interacts effectively [84]. The interdependence between the proportion of B-DNA and the Z-DNA conformation of the modified DNA and salt concentrations is shown in Table 2, which presents the preferential equilibrium.

3.1.1. C8-Methylation

The methylation of guanosine at the C8 position remarkably stabilizes the Z-conformation of oligonucleotides under physiological salt conditions [79,85,86]. The characterization of structural preferences was determined by CD spectra and the NMR of oligonucleotides incorporating 8-methylguanosine (Figure 6a,b). Figure 6 represents the signature bands of the CD spectral pattern for Z-DNA at 265 and 290 nm with positive and negative signs, respectively. Sugiyama et al. investigated the thermodynamic parameters of DNA B-Z transition for oligonucleotides containing 8-methylguanosine, and reported a reduction in entropic penalty by enthalpic gain during a Z-DNA formation [85]. Later, preferential structures of Z-DNA and RNA were investigated by CD spectra, and fluorescence detection was carried out by an electrophoretic mobility shift assay [86,87,88].
Figure 6. Graphical representations and CD spectra of the preferential structure of modified DNA. (a) DNA structure including purines modified with methylation (left), bromination (middle), and arylation (right); (b) CD spectra of 8-methyl ribo-guanosine incorporating oligomer stabilized the Z-DNA at low salt concentrations; (c) B-Z transition monitored by CD spectra. 8-Bromo-2′-deoxyguanosine containing an octamer sequence (d(CGTBrGCACG)2) dramatically stabilized the Z-form in low-salt physiological conditions; (d) CD spectra of the natural sequence and modified hairpin sequence in salt physiological condition from Ref. [89]. Arrows indicate the signature band of Z-DNA. Copyright (2003), (2004), and (2014), American Chemical Society.
Figure 6. Graphical representations and CD spectra of the preferential structure of modified DNA. (a) DNA structure including purines modified with methylation (left), bromination (middle), and arylation (right); (b) CD spectra of 8-methyl ribo-guanosine incorporating oligomer stabilized the Z-DNA at low salt concentrations; (c) B-Z transition monitored by CD spectra. 8-Bromo-2′-deoxyguanosine containing an octamer sequence (d(CGTBrGCACG)2) dramatically stabilized the Z-form in low-salt physiological conditions; (d) CD spectra of the natural sequence and modified hairpin sequence in salt physiological condition from Ref. [89]. Arrows indicate the signature band of Z-DNA. Copyright (2003), (2004), and (2014), American Chemical Society.
Ijms 22 09552 g006
Table 2. The midpoint of NaCl concentrations for the B to Z transition of DNA in various base-modified monomers incorporating d(CGCGCG)2 and poly(dG-dC).
Table 2. The midpoint of NaCl concentrations for the B to Z transition of DNA in various base-modified monomers incorporating d(CGCGCG)2 and poly(dG-dC).
EntrySequenceModificationMidpoint of (B–Z Transition)
NaCl Concentration (mM)
Reference
1d(CGCm8rGCG)2m8rG0[79]
2d(CGCFGCG)2FG20[88]
3d(CGCm8mGCG)2m8mG0[86]
4d(CGCm8GCG)2m8G30[90]
5Poly(dG-dC)Br-Poly(dG-dC)1000[91]

3.1.2. C8-Bromination

Brominated nucleobases, including poly(dG-dC), promote the stabilization of Z-DNA in low-salt physiological conditions [92]. As a result of bromination, 45% and 20% of guanine and cytosine, respectively, are brominated. The midpoint of B-Z transition is 0.15 M for brominated poly(dG-dC), which shows similar structural characteristics to those of unmodified poly(dG-dC) at 4M NaCl (Figure 6c) [91]. The shifts in equilibrium between B and Z conformations occur due to the steric hindrance of bromo-substitution at the C8 position. Moreover, the substitution of the bromo group interacts with the phosphate backbone of the DNA to form a syn conformation [93,94,95].

3.1.3. C8-Arylation

Arylation at the C8 position of guanosine is an important modification for the investigation of non-canonical structures, and these modified nucleosides also act as an internal probe. The carcinogenic adducts used for the substitution of guanosine at the C8 position have a significant influence on Z-DNA formation (Figure 7) [28,89,96,97]. The acetylaminofluorene (AAF) and aminofluorene (AF) adducts substituted into the C8 position of guanosine incorporated in poly(dG-dC)-AAF can adopt Z-form DNA without the presence of alcohol [98]. Recently, it was reported that guanosine inserted by ochratoxin A (OTA) into the C8 position can also adapt Z-form conformations, such as AAF and AF [99,100,101]. The 8-aryl-dG also destabilizes the B-DNA conformation and favors the Z-DNA conformation, since the steric factor helps glycosidic bond rotation to form syn conformations [32]. Those 8-arylated compounds exhibit a midpoint of B-Z transition at 0.6–0.8 M NaCl solution (Figure 7d) [89]. The synthesis of trifluoromethyl adduct involves guanine and incorporates oligonucleotide for the examination of the 19F NMR. The results show that 8-trifluoromethyl 2′-deoxyguanosine strongly supports the Z-DNA conformation in in vivo conditions [88] and C8-arylated guanosine is recognized by repair proteins, Rad14 and XPA [102].

3.2. G-Quadruplex

G4 is a four-stranded helical structure containing a G-tetrad stack, which is the result of the planar association of four guanines through Hoogsteen hydrogen bonds forming a cyclic square of G4 [16]. G4 was observed early in the self-assembly of guanylic acid and supports the elucidation of G-tetra-forming sequences. In the formation of G-tetra or G4, the guanine combines with three or more of each other to form a planar arrangement stabilized by positively charged ions and lone pair electrons from O6 of guanines. The monovalent ions, M+, are well known as the stabilizers of G4 among cations, and K+ is the most favorable cation [103,104,105,106,107]. Modified guanosines with relatively small substituents at the C8 position, such as bromine, methyl, and oxymethyl, have been used to investigate the structures of G4s [108,109,110]. There is an excellent review that interprets the CD spectra of G4 structures formed by the incorporation of 8-substituted guanosines [31].

3.2.1. C8-Methylation

The methyl-substituted guanosine at the C8 position (8-Me-dG) is also one of the stabilizers of G4 structures [111]. The patterns of CD spectra, along with the directions of G-tetra, are shown in Figure 8. For example, the incorporation of 8-Me-dG into (TGGGT)4 sequences at the second position gave an anti-parallel G4 in K+ ion solution, showing its CD spectra profile, which has a positive peak at 290 nm. In contrast, inserting 8-Me-dG at the third position caused a strong positive peak at 260 and a minor negative peak at 240 nm (Figure 8c) [111,112,113].
The biological significance of sequences containing 8-Me-dG has been investigated by the retinoblastoma gene, which acts as a tumor suppressor by interfering with the cell cycle. 8-Me-dG incorporates 18mer sequences that switched conformations between anti-parallel G4 with G-tetrads at neutral pH [37].

3.2.2. C8-Bromination

The bromination of guanine has been shown to have synthetic and biological significance, along with an advantageous glycosidic bond rotation syn conformation. [48,85,113,114,115]. The incorporation of brominated guanosine (8-Br-dG) into oligonucleotides increases the thermal stability along with the number of substitutions. The thermal stability of oligonucleotide increases by 5–6 °C, while the other four additions of 8-Br-dG into oligonucleotides reduce the stability by 3–6 °C [116]. Different topological structures containing 8-Br-dG in different locations were characterized by the CD spectra. An anti-parallel G4 shows a positive cotton effect at 295nm and a negative peak near 260 nm [108,117,118,119].

3.2.3. Other Modifications at the C8 Position

The 8-oxoguanine (O8G) substitution preferred the form of a syn conformation (Figure 7d). The substitution at the 5′ position led to the formation of tetra molecular G4 [120]. The effect of O8G on the activity of the telomerase enzyme was investigated in the electrochemical measurements [121]. The substitution of O8G at 8 and 14 positions in G4 contributes to decreasing the telomerase activity, but the substitution of the GGG triplet at 9 and 15 positions led to an increase in the enzymatic activity.
8-amino-2′-deoxyguanosine (8AG) is one of the mutagenic intermediates observed in cellular DNA. 8AG (Figure 7d) can destabilize parallel, anti-parallel, and triplex formations due to the increase in the free energy of each substation of 1–4 kcal/mol [122]. The G4 structure is destabilized at 7 °C due to the incorporation of 8AG into the 15 mer DNA, while the unmodified 15 mer forms an anti-parallel G4 structure. The CD spectra profile data show that the 8-amino-2′-deoxyguanosine (8AG) incorporated a GGTTGGTGTGGTTGG sequence, different from the unmodified 15 mer structures.
Internal fluorescent probes have more advantages in terms of detecting the structural properties of G4. 8-(2-pyridyl) guanine (2PyG) is an internal fluorescent compound, as the coordination between G4 and cations induces efficient DNA-to-probe energy transfer [114]. The coordination of cations at the O6 position produced a strong energy transfer due to the smaller distance between the cation and 2PyG at the turn site. Two fluorescent probes, 8-(2-phenylethenyl)-dG and 8-[2-(pyrid-4-yl)-ethenyl]-dG, show a high structural selectivity [123,124]. Forming a G4 structure results in a stronger fluorescence signal than single-strand or duplex because these internal probes detect the characteristics of secondary structures and spectroscopic properties. Interestingly, the structural changes in the 8-fluorenylvinyl-dG (Fv8G) are able to control the G4 formation [125]. This photo-switchable G4 formation can be applied to the biological events involving G4s.

4. Synthesis of C5-Modified Pyrimidine

Several pyrimidine modifications have been observed in DNA. Most of the changes are correlated with DNA mutation, such as oxidation, methylation, and nitration. The purine modification mainly focuses on the C5 position. Numerous modifications at the C5 position containing purine have been synthesized in the past four decades, such as methylated pyrimidines, brominated pyrimidines, and arylated pyrimidines (Figure 9). These modified purines represent potent candidates for biological analysis and are used to investigate secondary structures of DNA [44,126,127,128,129].

4.1. Synthesis of C5-Methylpyrimidine

Cytosine is commonly methylated at the C5 position, as it is the most abundant endogenous modification of DNA with approximately 5% of all cytosine bases carrying a C5 methyl group [130]. 5-methylcytosine plays a crucial role in the tissue-specific gene expression pattern, the inactivation of X-chromosome activity, and genomic imprinting [131,132,133]. The 5-methyl uracil used for the photochemistry as the probe has a potency of antimicrobial activity [134,135,136,137,138]. Reactions of 5-substitution for pyrimidine have been developed based on the C-H activation, palladium coupling reaction, and the addition of formaldehyde [8,139,140]. In addition, efficient methodologies have been reported for the synthesis of methylated pyrimidines [141,142,143,144,145]. Methylated and hydroxymethylated cytosines are recognized by restriction endonuclease enzyme (LpnPI), zinc-finger protein Kaiso and SUVH5 [146].

4.2. Synthesis of C5-Bromopyrimidine

The C5-bromination of pyrimidine has significant antimicrobial properties that can be used for therapeutic purposes [50]. For instance, it was recently reported that the 5-bromoethylnyluridine possesses anti-HCV properties [147]. 5-bromopyrimidines are used for the structural elucidation of mismatched base pairs with normal base pairs to explain mutagenic pathways and properties. C5-bromination, used for the preparation of antisense, also utilizes for the radioactive labeling, stabilization for a triplex, and investigation of endonucleases activity [148,149,150,151]. Various 5-halopyrimidines and their derivatives have biological effects such as antibacterial activity, oncology therapeutics, and are involved in the investigation the nucleic acid damage and metabolism [50]. Halogenated pyrimidines are used for labeling. For example, 5-BrU is labeled with RNA during the RNA synthesis process [152] and 5-BrU contains DNA-RNA hybrid duplex sequences with polypurine RNA sequences. 5-BrU was also used to study the A-form structure of DNA-RNA hybrid duplex by X-ray crystal structure [153]. C5-bromination or iodination has been achieved using halogenation agents, such as N-iodosuccinimide, nitric acid, or N-Bromosuccinimide [49,154,155,156,157].

4.3. Synthesis of C5-Arylpyrimidine

Pyrimidine nucleosides substituted at the C5 position have a high potential for antiviral, antibacterial, and anti-fungal activity [155,158,159,160]. Pd-catalyzed cross-coupling reactions have been extensively developed that possess over the past 40 years and have become one of the important methodologies for arylation at the C5 position of nucleosides [68,139,161,162,163]. For example, the arylation at the C5 position of the uracil ring has been accomplished by various coupling reactions, such as the Suzuki coupling reaction [68,164,165,166,167]. Despite the critical role of the arylation at the C5 position in pyrimidines, the direct C-H arylation of pyrimidine nucleoside bases is nowadays limited to uracil nucleoside bases [25,160,168,169,170]. This is because the C–H bond functionalization of pyrimidine is difficult for controlling the regioselectivity due to the acidic characteristics of C5 and C6 protons. More developments of C–H bond functionalization to pyrimidine analogues have been performed. For effective reactions, for the regioselective C-H arylation reactions, various agents have been used such as the activated palladium precursor complexes, carbonate, and acetate [171,172,173].

5. Non-Canonical Structure Containing C5-Modified Pyrimidine

Chemical modifications of nucleoside at the C5 position can provide more stability to non-canonical structures of oligonucleotides. These systems have been developed to understand their structure, folding properties, and biological importance. Here, we highlight the major contributions of nucleoside modifications to the study of Z-DNA, G-quadruplexes, i-motifs, and triple helices. The characteristics of structural preferences in non-canonical structures containing modified bases were determined by spectroscopic profiles (Figure 10).

5.1. Z-DNA

Several studies have shown that chemically modified nucleosides enable oligonucleotides to stabilize Z-form rather than B-form [174]. For instance, the methylation of cytosine is able to induce the B-Z transition of DNA in synthetic d(Gm5C)n polynucleotides [175,176,177]. Other modifications of the d(GpC) also stabilize the Z-form of DNA by substitutions, such as iodine, bromine, and aza, at the C5 position [178]. More details are discussed in this section.

5.1.1. C5-Methylation

The most predominant modification associate with gene silencing is methylation of cytosine at the C5 position. Oxidation of pyrimidine naturally occurred in a process catalyzed by translocation (TET) family proteins. The common oxidative methylation is methylation at the C5 position of pyrimidines. Several C5-modified cytosines such as 5-formylcytosine (5fC), 5-hydroxymethylcytosine (5hmC), and 5-carboxylcytosine (5caC) can be involved in C5-methyl cytosines mediate gene expression [179,180,181,182]. The presence or absence of methylation in the CG sequence is in favor of forming Z-DNA. In comparison with unmodified poly(CG), poly(m5CG) sequences show a significant potential to form Z-DNA, in particular, under the divalent cation such as Mg2+, which was used for prior Z-DNA studies [175]. Spectroscopic experimental results, along with calculations, support that van der Waal interaction with hydrophobic elements on the molecular surface may contribute to forming Z-DNA [13,183,184,185]. Moreover, sugar modification both with unmodified and modified bases of d(CG)n tends to form Z-conformation [174,186]. Simulation trajectories can provide the molecular characteristics of the role of methylation in CG repeated units [187]. Although AT base pairs form fewer Z-conformation than CG base pairs, oligonucleotides containing AT base pairs can also form Z-DNA with C5-methylcytosine [177]. It has been suggested that disordered hydrating water molecules may contribute to the position reducing the relative stability of the Z-form to CG base pair.

5.1.2. C5-Bromination

Bromination of cytosine at the C5 position in CG sequences can stabilize Z-conformation in common with methylation at the C5 position [91,93,188]. In high-concentration solutions, brominated cytosine produces Z-DNA conformations similar to unmodified DNA [91,189,190]. In addition, both DNA and RNA containing bromination at C5 can stabilize Z-conformation at low salt physiological conditions [191]. The structure of Z-RNA allows hydroxyl groups at the sugar backbone of guanosine to be exposed to the surface of the helix, which can involve in the recognition of protein binding.

5.2. G-Quadruplex

C5-methylation of cytosine can induce conformational changes of the G-quadruplex structure. Whereas the wild-type G-quadruplex sequence exhibits a mixture of parallel and anti-parallel structure [192], the corresponding sequence containing 5-methyl cytosine showed only parallel G-quadruplex structure, which typically shows positive and negative CD profiles at 265 and 240 nm, respectively (Figure 7b,c) [193]. It was demonstrated that the methylated cytosine involves a formation of G-quadruplex that interferes CCCTC-binding factor along with the flipping process from hairpin to quadruplex [194].
The replacement of 5-halogen modified deoxyuridine (dU) instead of T in the DNA sequence also affected the G-quadruplex conformation. The htel-22mer, AG3(TTAG3)3, and [G4T4G4]2 sequences containing the 5-iodo dU (5I-dU) instead of T prefer to form an anti-parallel G-quadruplex structure under Na+ condition rather than a mixture of G-quadruplex structures [195]. Interestingly, under K+ conditions, these 5-halogenated dU sequences folded different loop structures to G-quadruplex structures of the same modified DNA under Na+ conditions [196].

5.3. i-Motif Structure

The i-motif structure is one of the non-canonical structures of nucleic acids that have two parallel duplexes held together by hemiprotonated cytidine and protonated cytidine (C:C+) base-pairs intercalated in an antiparallel orientation (Figure 10b) [197,198]. The i-motif requires the protonated bases and thus is more stabilized under an acidic pH condition [199]. It was reported that the chemically modified cytosine exhibits different effects on the formation of i-motif structure under physiological conditions [200,201,202]. The halogenation of dC at the C5 position leads to the acceleration of the folding kinetics in the i-motif structure [203]. In addition, the incorporation of a methyl group at the C5 position of cytosine into the i-motif sequence increases the stability and thus changes pH dependence [203,204,205]. CD spectra for i-motif modified by methyl group show variation of profiles due to change of folded fraction at different pH (Figure 10c).
The interaction between hemi protonated C:C+ base pairs that form hydrogen bonds of i-motif in oligonucleotides have been investigated by various approaches such as base-pair opening kinetics, FRET experiments, and the base-pairing energy (BPE) calculation [206,207,208,209,210]. It has been demonstrated by NMR results that motion consists of a cooperative switch between two conformations of loop1 and loop3 of i-motif containing modified sequence [209]. Moreover, the BPE of the C:C+ base pair for methylated cytosine at the C5 position is much greater than the canonical Watson–Crick base pair [210]. In addition, the chemically modified nucleobases are used to form an i-motif structure of DNA under the neutral physiological condition [211].

5.4. Triple Helix

A triplex structure of nucleic acids is formed by additional Hoogsteen pairing of pyrimidine or purine bases, which occupy the major groove of the double helix, with purines of the Watson–Crick base-pairs [213]. Intermolecular DNA triplexes are formed by the interaction of triplex-forming oligonucleotides (TFOs) with target unique sequences by forming triplex following hydrogen bonding interactions between TFOs and the oligopurine strand of the duplex (Figure 10b). The TFOs containing the chemically modified nucleotide, particularly modified pyrimidine, significantly stabilize the formation of triplex structure than unmodified TFOs [214,215,216]. The structural property of triplex shows significantly different CD profile to CD spectral patterns of DNA duplex or TFO (Figure 10c). In addition, various analogs of modified uracil at the C5 position have been explored for the investigation of sequence selectivity and affinity of TFO [217]. TFO incorporated with C5-alkynyl functionalized LNA monomers dramatically stabilizes triplex formation and increases thermal stability [218]. The 5-(1-propynyl)-2′-deoxyuridine (pdU)-modified TFO, which targeted the A-rich site, formed the stable triplex structure, and required a lower concentration of Mg2+ cation to form triplex compared to unmodified TFOs. Interestingly, the pdU contains the TFOs more effectively than T-containing TFOs to direct the DNA. There are comprehensive reviews of the structural studies of the triplex based on chemical modifications [5,219,220].

6. Conclusions

Knowing the chemical alterations of purine nucleosides is important to better understand the structure and function of non-canonical DNA. Nucleoside modifications, such as methylation, bromination, and arylation, especially at the C8 position of purine and the C5 position of pyrimidine, are powerful tools not only to analyze the sequence-dependent structure of DNA, but also to investigate its roles in biological processes. For example, methylated nucleosides are used to investigate epigenetic regulation of cellular differentiation mechanisms.
This paper provides an overview of how the structure of non-canonical DNA can be influenced by DNA alterations at the C8 and C5 positions of nucleosides. Modified bases contain DNA sequence stability that differs from natural sequences. Most of the modifications either destabilize the local DNA structure or induce the formation of alternative secondary structures [221]. The recent studies of dsDNA or siRNA containing modified purines or uridines show that more modified bases actively alter genomic stability [222]. We predict that the effort to discover the underlying principles behind the link between local structure and base modifications will provide the key to elucidating the mechanism of how modifications affect genetic stability.
The developments of a more efficient methodology for the direct chemical modification at the specific position have been applied using brominating agents or Pd catalysis synthesis protocols. The field of research on pyrimidine arylation is narrow, as most of the pyrimidine arylation mainly focuses on uracil and its derivatives that have therapeutical roles. Further developments of the chemically synthetic methods and the characterization of the structural properties of modified DNA will make it possible to unveil the function of non-canonical DNA.

Author Contributions

Conceptualization, T.B., B.-S.K. and J.-H.L.; writing—original draft preparation, T.B., H.-S.J. and H.-B.A.; writing—review and editing, K.-I.O., B.-S.K. and J.-H.L.; supervision, B.-S.K. and J.-H.L.; project administration, B.-S.K. and J.-H.L.; funding acquisition, J.-H.L., B.-S.K. and K.-I.O. All authors have read and agreed to the published version of the manuscript.

Funding

This work was supported by the National Research Foundation of Korea (2020R1A2C1006909 to J.-H.L., 2020R1C1C1013785 to B-S.K. and 2020R1I1A1A01070690 to K.-I.O.). This work was also supported by the Samsung Science and Technology Foundation (SSTF-BA1701-10 to J.-H.L.) and a KBSI grant [C030440].

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Conflicts of Interest

Authors declare that they have no conflict of interest.

References

  1. Freier, S.M.; Altmann, K.-H. The ups and downs of nucleic acid duplex stability: Structure-stability studies on chemically-modified DNA:RNA duplexes. Nucleic Acids Res. 1997, 25, 4429–4443. [Google Scholar] [CrossRef] [Green Version]
  2. Pinheiro, V.B.; Taylor, A.I.; Cozens, C.; Abramov, M.; Renders, M.; Zhang, S.; Chaput, J.C.; Wengel, J.; Peak-Chew, S.-Y.; McLaughlin, S.H.; et al. Synthetic Genetic Polymers Capable of Heredity and Evolution. Science 2012, 336, 341. [Google Scholar] [CrossRef] [Green Version]
  3. Ni, S.; Yao, H.; Wang, L.; Lu, J.; Jiang, F.; Lu, A.; Zhang, G. Chemical Modifications of Nucleic Acid Aptamers for Therapeutic Purposes. Int. J. Mol. Sci. 2017, 18, 1683. [Google Scholar] [CrossRef]
  4. Goodchild, J. Conjugates of oligonucleotides and modified oligonucleotides: A review of their synthesis and properties. Bioconjugate Chem. 1990, 1, 165–187. [Google Scholar] [CrossRef] [PubMed]
  5. Doluca, O.; Withers, J.M.; Filichev, V.V. Molecular engineering of guanine-rich sequences: Z-DNA, DNA triplexes, and G-quadruplexes. Chem. Rev. 2013, 113, 3044–3083. [Google Scholar] [CrossRef] [PubMed]
  6. Saito, Y.; Hudson, R.H.E. Base-modified fluorescent purine nucleosides and nucleotides for use in oligonucleotide probes. J. Photochem. Photobiol. C 2018, 36, 48–73. [Google Scholar] [CrossRef]
  7. McKenzie, L.K.; El-Khoury, R.; Thorpe, J.D.; Damha, M.J.; Hollenstein, M. Recent progress in non-native nucleic acid modifications. Chem. Soc. Rev. 2021, 50, 5126–5164. [Google Scholar] [CrossRef]
  8. Cline, R.E.; Fink, R.M.; Fink, K. Synthesis of 5-Substituted Pyrimidines via Formaldehyde Addition1. J. Am. Chem. Soc. 1959, 81, 2521–2527. [Google Scholar] [CrossRef]
  9. Frisch, D.M.; Visser, D.W. 5-Bromodeoxycytidine and 5-Chlorodeoxycytidine1. J. Am. Chem. Soc. 1959, 81, 1756–1758. [Google Scholar] [CrossRef]
  10. Uesugi, S.; Ikehara, M. Carbon-13 magnetic resonance spectra of 8-substituted purine nucleosides. Characteristic shifts for the syn conformation. J. Am. Chem. Soc. 1977, 99, 3250–3253. [Google Scholar] [CrossRef]
  11. Vongsutilers, V.; Phillips, D.J.; Train, B.C.; McKelvey, G.R.; Thomsen, N.M.; Shaughnessy, K.H.; Lewis, J.P.; Gannett, P.M. The conformational effect of para-substituted C8-arylguanine adducts on the B/Z-DNA equilibrium. Biophys. Chem. 2011, 154, 41–48. [Google Scholar] [CrossRef]
  12. Watson, J.D.; Crick, F.H.C. Molecular Structure of Nucleic Acids: A Structure for Deoxyribose Nucleic Acid. Nature 1953, 171, 737–738. [Google Scholar] [CrossRef] [PubMed]
  13. Rich, A.; Zhang, S. Timeline: Z-DNA: The long road to biological function. Nat. Rev. Genet. 2003, 4, 566–572. [Google Scholar] [CrossRef]
  14. Wang, A.H.; Quigley, G.J.; Kolpak, F.J.; Crawford, J.L.; van Boom, J.H.; van der Marel, G.; Rich, A. Molecular structure of a left-handed double helical DNA fragment at atomic resolution. Nature 1979, 282, 680–686. [Google Scholar] [CrossRef] [PubMed]
  15. Ha, S.C.; Lowenhaupt, K.; Rich, A.; Kim, Y.G.; Kim, K.K. Crystal structure of a junction between B-DNA and Z-DNA reveals two extruded bases. Nature 2005, 437, 1183–1186. [Google Scholar] [CrossRef]
  16. Gros, J.; Rosu, F.; Amrane, S.; De Cian, A.; Gabelica, V.; Lacroix, L.; Mergny, J.L. Guanines are a quartet’s best friend: Impact of base substitutions on the kinetics and stability of tetramolecular quadruplexes. Nucleic Acids Res. 2007, 35, 3064–3075. [Google Scholar] [CrossRef]
  17. Davis, J.T. G-quartets 40 years later: From 5′-GMP to molecular biology and supramolecular chemistry. Angew. Chem. Int. Ed. Engl. 2004, 43, 668–698. [Google Scholar] [CrossRef] [PubMed]
  18. Sun, Z.Y.; Wang, X.N.; Cheng, S.Q.; Su, X.X.; Ou, T.M. Developing Novel G-Quadruplex Ligands: From Interaction with Nucleic Acids to Interfering with Nucleic Acid(-)Protein Interaction. Molecules 2019, 24, 396. [Google Scholar] [CrossRef] [Green Version]
  19. Wittig, B.; Wölfl, S.; Dorbic, T.; Vahrson, W.; Rich, A. Transcription of human c-myc in permeabilized nuclei is associated with formation of Z-DNA in three discrete regions of the gene. EMBO J. 1992, 11, 4653–4663. [Google Scholar] [CrossRef]
  20. Maruyama, A.; Mimura, J.; Harada, N.; Itoh, K. Nrf2 activation is associated with Z-DNA formation in the human HO-1 promoter. Nucleic Acids Res. 2013, 41, 5223–5234. [Google Scholar] [CrossRef] [Green Version]
  21. Manderville, R.A.; Wetmore, S.D. C-Linked 8-aryl guanine nucleobase adducts: Biological outcomes and utility as fluorescent probes. Chem. Sci. 2016, 7, 3482–3493. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  22. Xodo, L.E.; Manzini, G.; Quadrifoglio, F.; van der Marel, G.A.; van Boom, J.H. Effect pf 5-methylcytosine on the stability of triple-stranded DNA—a thermodynamic study. Nucleic Acids Res. 1991, 19, 5625–5631. [Google Scholar] [CrossRef] [PubMed]
  23. Ontiveros, R.J.; Stoute, J.; Liu, K.F. The chemical diversity of RNA modifications. Biochem. J. 2019, 476, 1227–1245. [Google Scholar] [CrossRef]
  24. Tateishi-Karimata, H.; Sugimoto, N. Chemical biology of non-canonical structures of nucleic acids for therapeutic applications. Chem. Comm. 2020, 56, 2379–2390. [Google Scholar] [CrossRef] [PubMed]
  25. Ngassa, F.N.; Dekorver, K.A.; Melistas, T.S.; Yeh, E.A.; Lakshman, M.K. Pd-Xantphos-catalyzed direct arylation of nucleosides. Org. Lett. 2006, 8, 4613–4616. [Google Scholar] [CrossRef] [PubMed]
  26. Bhilare, S.; Gayakhe, V.; Ardhapure, A.V.; Sanghvi, Y.S.; Schulzke, C.; Borozdina, Y.; Kapdi, A.R. Novel water-soluble phosphatriazenes: Versatile ligands for Suzuki-Miyaura, Sonogashira and Heck reactions of nucleosides. RSC Adv. 2016, 6, 83820–83830. [Google Scholar] [CrossRef]
  27. Thomsen, N.M.; Vongsutilers, V.; Gannett, P.M. The synthesis of C8-aryl purines, nucleosides and phosphoramidites. Crit. Rev. Eukaryot. Gene Expr. 2011, 21, 155–176. [Google Scholar] [CrossRef]
  28. Hingerty, B.; Broyde, S. Conformation of the deoxydinucleoside monophosphate dCpdG modified at carbon 8 of guanine with 2-(acetylamino)fluorene. Biochemistry 1982, 21, 3243–3252. [Google Scholar] [CrossRef] [PubMed]
  29. Araki, M.; Maeda, M.; Kawazoe, Y. Chemical alteration of nucleic acids and their components—XIII. Tetrahedron 1976, 32, 337–340. [Google Scholar] [CrossRef]
  30. Humphreys, W.G.; Kadlubar, F.F.; Guengerich, F.P. Mechanism of C8 alkylation of guanine residues by activated arylamines: Evidence for initial adduct formation at the N7 position. Proc. Natl. Acad. Sci. USA 1992, 89, 8278–8282. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  31. Masiero, S.; Trotta, R.; Pieraccini, S.; De Tito, S.; Perone, R.; Randazzo, A.; Spada, G.P. A non-empirical chromophoric interpretation of CD spectra of DNA G-quadruplex structures. Org. Biomol. Chem. 2010, 8, 2683–2692. [Google Scholar] [CrossRef]
  32. Gannett, P.M.; Heavner, S.; Daft, J.R.; Shaughnessy, K.H.; Epperson, J.D.; Greenbaum, N.L. Synthesis, properties, and NMR studies of a C8-phenylguanine modified oligonucleotide that preferentially adopts the Z DNA conformation. Chem. Res. Toxicol. 2003, 16, 1385–1394. [Google Scholar] [CrossRef]
  33. Rice, J.M.; Dudek, G.O. Mass spectra of nucleic acid derivatives. II. Guanine, adenine, and related compounds. J. Am. Chem. Soc. 1967, 89, 2719–2725. [Google Scholar] [CrossRef] [PubMed]
  34. Jones, J.W.; Robins, R.K. Purine Nucleosides. III. Methylation Studies of Certain Naturally Occurring Purine Nucleosides. J. Am. Chem. Soc. 1963, 85, 193–201. [Google Scholar] [CrossRef]
  35. Rogers, K.J.; Pegg, A.E. Formation of O6-methylguanine by alkylation of rat liver, colon, and kidney DNA following administration of 1,2-dimethylhydrazine. Cancer Res. 1977, 37, 4082–4087. [Google Scholar] [PubMed]
  36. Araie, Y.; Ohtsuki, S.; Park, S.; Nagaoka, M.; Umemura, K.; Sugiyama, H.; Kusamori, K.; Takahashi, Y.; Takakura, Y.; Nishikawa, M. Combined use of chemically modified nucleobases and nanostructured DNA for enhanced immunostimulatory activity of CpG oligodeoxynucleotide. Bioorgan. Med. Chem. 2021, 29, 115864. [Google Scholar] [CrossRef] [PubMed]
  37. Virgilio, A.; Esposito, V.; Citarella, G.; Pepe, A.; Mayol, L.; Galeone, A. The insertion of two 8-methyl-2′-deoxyguanosine residues in tetramolecular quadruplex structures: Trying to orientate the strands. Nucleic Acids Res. 2012, 40, 461–475. [Google Scholar] [CrossRef] [Green Version]
  38. Thomson, J.M.; Lamont, I.L. Nucleoside Analogues as Antibacterial Agents. Front. Microbiol. 2019, 10, 952. [Google Scholar] [CrossRef] [Green Version]
  39. Maeda, M.; Nushi, K.; Kawazoe, Y. Studies on chemical alterations of nucleic acids and their components—VII. Tetrahedron 1974, 30, 2677–2682. [Google Scholar] [CrossRef]
  40. Kohda, K.; Tsunomoto, H.; Minoura, Y.; Tanabe, K.; Shibutani, S. Synthesis, miscoding specificity, and thermodynamic stability of oligodeoxynucleotide containing 8-methyl-2′-deoxyguanosine. Chem. Res. Toxicol. 1996, 9, 1278–1284. [Google Scholar] [CrossRef]
  41. Martinez, G.R.; Gasparutto, D.; Ravanat, J.L.; Cadet, J.; Medeiros, M.H.; Di Mascio, P. Identification of the main oxidation products of 8-methoxy-2′-deoxyguanosine by singlet molecular oxygen. Free Radic. Biol. Med. 2005, 38, 1491–1500. [Google Scholar] [CrossRef]
  42. Crean, C.; Geacintov, N.E.; Shafirovich, V. Methylation of 2′-deoxyguanosine by a free radical mechanism. J. Phys. Chem. B 2009, 113, 12773–12781. [Google Scholar] [CrossRef] [Green Version]
  43. Zady, M.F.; Wong, J.L. Kinetics and mechanism of carbon-8 methylation of purine bases and nucleosides by methyl radical. J. Am. Chem. Soc. 1977, 99, 5096–5101. [Google Scholar] [CrossRef] [PubMed]
  44. Elskens, J.; Manicardi, A.; Costi, V.; Madder, A.; Corradini, R. Synthesis and Improved Cross-Linking Properties of C5-Modified Furan Bearing PNAs. Molecules 2017, 22, 2010. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  45. Niu, H.-Y.; Su, L.-Y.; Bai, S.-X.; Li, J.-P.; Feng, X.-L.; Guo, H.-M. Synthesis of C8-alkyl-substituted purine analogues by direct alkylation of 8- H purines with tetrahydrofuran catalyzed by CoCl2·6H2O. Chin. Chem. Lett. 2017, 28, 105–108. [Google Scholar] [CrossRef]
  46. Yamazaki, A.; Kumashiro, I.; Takenishi, T. Synthesis of guanosine and its derivatives from 5-amino-1-beta-D-ribofuranosyl-4-imidazolecarboxamide. II. Ring closure with sodium methylxanthate. J. Org. Chem. 1967, 32, 3032–3038. [Google Scholar] [CrossRef]
  47. Pfleiderer, W.; Shanshal, M.; Eistetter, K. Nucleosides, V. Synthesis and structure of 8-methyl- and 8-(trifluoromethyl) guanine nucleosides. Chem. Ber. 1972, 105, 1497–1509. [Google Scholar] [CrossRef] [PubMed]
  48. Ikehara, M.; Limn, W.; Fukui, T. Studies of nucleosides and nucleotides. LXXXI. Synthesis and characterization of 8-methyladenosine. Chem. Pharm. Bull. 1977, 25, 2702–2707. [Google Scholar] [CrossRef] [Green Version]
  49. Hirota, K.; Kitade, Y.; Kanbe, Y.; Maki, Y. Convenient method for the synthesis of C-alkylated purine nucleosides: Palladium-catalyzed cross-coupling reaction of halogenopurine nucleosides with trialkylaluminums. J. Org. Chem. 1992, 57, 5268–5270. [Google Scholar] [CrossRef]
  50. Henderson, J.P.; Byun, J.; Williams, M.V.; McCormick, M.L.; Parks, W.C.; Ridnour, L.A.; Heinecke, J.W. Bromination of deoxycytidine by eosinophil peroxidase: A mechanism for mutagenesis by oxidative damage of nucleotide precursors. Proc. Natl. Acad. Sci. USA 2001, 98, 1631–1636. [Google Scholar] [CrossRef]
  51. Volpini, R.; Costanzi, S.; Lambertucci, C.; Vittori, S.; Klotz, K.; Lorenzen, A.; Cristalli, G. Introduction of alkynyl chains on C-8 of adenosine led to very selective antagonists of the A(3) adenosine receptor. Bioorgan. Med. Chem. Lett. 2001, 11, 1931–1934. [Google Scholar] [CrossRef]
  52. El Safadi, Y.; Marquet, R.; Aubertin, A.M.; Vivet-Boudou, V. Synthesis and primary evaluation of novel HIV-1 inhibitors. Nucleosides Nucleotides Nucleic Acids 2007, 26, 1161–1165. [Google Scholar] [CrossRef]
  53. Asahi, T.; Kondo, H.; Masuda, M.; Nishino, H.; Aratani, Y.; Naito, Y.; Yoshikawa, T.; Hisaka, S.; Kato, Y.; Osawa, T. Chemical and immunochemical detection of 8-halogenated deoxyguanosines at early stage inflammation. J. Biol. Chem. 2010, 285, 9282–9291. [Google Scholar] [CrossRef] [Green Version]
  54. Budovskii, E.I.; Shibaev, V.N.; Spiridonova, S.M.; Kochetkov, N.K. Synthesis of 8-bromoadenosine 5′-(α-D-glucopyranosyl diphosphate). Bull. Acad. Sci. USSR Div. Chem. Sci. 1971, 20, 1183–1185. [Google Scholar] [CrossRef]
  55. Münzel, M.; Szeibert, C.; Glas, A.F.; Globisch, D.; Carell, T. Discovery and Synthesis of New UV-Induced Intrastrand C(4−8)G and G(8−4)C Photolesions. J. Am. Chem. Soc. 2011, 133, 5186–5189. [Google Scholar] [CrossRef]
  56. Ikehara, M.; Kaneko, M. Studies of nucleosides and nucleotides—XLI. Tetrahedron 1970, 26, 4251–4259. [Google Scholar] [CrossRef]
  57. Maity, J.; Stromberg, R. An efficient and facile methodology for bromination of pyrimidine and purine nucleosides with sodium monobromoisocyanurate (SMBI). Molecules 2013, 18, 12740–12750. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  58. Asahi, T.; Nakamura, Y.; Kato, Y.; Osawa, T. Specific role of taurine in the 8-brominated′-deoxyguanosine formation. Arch. Biochem. Biophys. 2015, 586, 45–50. [Google Scholar] [CrossRef]
  59. Varizhuk, A.M.; Zatsepin, T.S.; Golovin, A.V.; Belyaev, E.S.; Kostyukevich, Y.I.; Dedkov, V.G.; Shipulin, G.A.; Shpakovski, G.V.; Aralov, A.V. Synthesis of oligonucleotides containing novel G-clamp analogue with C8-tethered group in phenoxazine ring: Implication to qPCR detection of the low-copy Kemerovo virus dsRNA. Bioorgan. Med. Chem. 2017, 25, 3597–3605. [Google Scholar] [CrossRef] [PubMed]
  60. Gillet, L.C.J.; Schärer, O.D. Preparation of C8-Amine and Acetylamine Adducts of 2′-Deoxyguanosine Suitably Protected for DNA Synthesis. Org. Lett. 2002, 4, 4205–4208. [Google Scholar] [CrossRef] [PubMed]
  61. Seregin, I.V.; Gevorgyan, V. Direct transition metal-catalyzed functionalization of heteroaromatic compounds. Chem. Soc. Rev. 2007, 36, 1173–1193. [Google Scholar] [CrossRef] [PubMed]
  62. Čerňa, I.; Pohl, R.; Hocek, M. The first direct C–H arylation of purinenucleosides. Chem. Comm. 2007, 4729–4730. [Google Scholar] [CrossRef] [PubMed]
  63. Kanda, T.; Jackson, M.J.; Smith, L.A.; Pearce, R.K.; Nakamura, J.; Kase, H.; Kuwana, Y.; Jenner, P. Adenosine A2A antagonist: A novel antiparkinsonian agent that does not provoke dyskinesia in parkinsonian monkeys. Ann. Neurol. 1998, 43, 507–513. [Google Scholar] [CrossRef] [PubMed]
  64. Gudmundsson, K.S.; Daluge, S.M.; Condreay, L.D.; Johnson, L.C. Synthesis of novel 8-substituted carbocyclic analogs of 2′,3′-dideoxyadenosine with activity against hepatitis B virus. Nucleosides Nucleotides Nucleic Acids 2002, 21, 891–901. [Google Scholar] [CrossRef]
  65. Carothers, A.M.; Yuan, W.; Hingerty, B.E.; Broyde, S.; Grunberger, D.; Snyderwine, E.G. Mutation and repair induced by the carcinogen 2-(hydroxyamino)-1-methyl-6-phenylimidazo[4,5-b]pyridine (N-OH-PhIP) in the dihydrofolate reductase gene of Chinese hamster ovary cells and conformational modeling of the dG-C8-PhIP adduct in DNA. Chem. Res. Toxicol. 1994, 7, 209–218. [Google Scholar] [CrossRef] [PubMed]
  66. De Leeuw, W.J.; van Puijenbroek, M.; Merx, R.; Wijnen, J.T.; Bröcker-Vriends, A.H.; Tops, C.; Vasen, H.; Cornelisse, C.J.; Morreau, H. Bias in detection of instability of the (C)8 mononucleotide repeat of MSH6 in tumours from HNPCC patients. Oncogene 2001, 20, 6241–6244. [Google Scholar] [CrossRef]
  67. Kuska, M.S.; Witham, A.A.; Sproviero, M.; Manderville, R.A.; Majdi Yazdi, M.; Sharma, P.; Wetmore, S.D. Structural influence of C8-phenoxy-guanine in the NarI recognition DNA sequence. Chem. Res. Toxicol. 2013, 26, 1397–1408. [Google Scholar] [CrossRef] [PubMed]
  68. Agrofoglio, L.A.; Gillaizeau, I.; Saito, Y. Palladium-assisted routes to nucleosides. Chem. Rev. 2003, 103, 1875–1916. [Google Scholar] [CrossRef] [PubMed]
  69. Western, E.C.; Shaughnessy, K.H. Inhibitory Effects of the Guanine Moiety on Suzuki Couplings of Unprotected Halonucleosides in Aqueous Media. J. Org. Chem. 2005, 70, 6378–6388. [Google Scholar] [CrossRef]
  70. Vaňková, B.; Krchňák, V.; Soural, M.; Hlaváč, J. Direct C–H Arylation of Purine on Solid Phase and Its Use for Chemical Libraries Synthesis. ACS Comb. Sci. 2011, 13, 496–500. [Google Scholar] [CrossRef]
  71. Abdoli, M.; Mirjafary, Z.; Saeidian, H.; Kakanejadifard, A. New developments in direct functionalization of C–H and N–H bonds of purine bases via metal catalyzed cross-coupling reactions. RSC Adv. 2015, 5, 44371–44389. [Google Scholar] [CrossRef]
  72. Omumi, A.; Beach, D.G.; Baker, M.; Gabryelski, W.; Manderville, R.A. Postsynthetic Guanine Arylation of DNA by Suzuki−Miyaura Cross-Coupling. J. Am. Chem. Soc. 2011, 133, 42–50. [Google Scholar] [CrossRef] [PubMed]
  73. Aguiar, P.H.N.; Furtado, C.; Repolês, B.M.; Ribeiro, G.A.; Mendes, I.C.; Peloso, E.F.; Gadelha, F.R.; Macedo, A.M.; Franco, G.R.; Pena, S.D.J.; et al. Oxidative Stress and DNA Lesions: The Role of 8-Oxoguanine Lesions in Trypanosoma cruzi Cell Viability. PLoS Neglected Trop. Dis. 2013, 7, e2279. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  74. Tchou, J.; Bodepudi, V.; Shibutani, S.; Antoshechkin, I.; Miller, J.; Grollman, A.P.; Johnson, F. Substrate specificity of Fpg protein. Recognition and cleavage of oxidatively damaged DNA. J. Biol. Chem. 1994, 269, 15318–15324. [Google Scholar] [CrossRef]
  75. Dai, Q.; Xu, D.; Lim, K.; Harvey, R.G. Efficient Syntheses of C8-Aryl Adducts of Adenine and Guanine Formed by Reaction of Radical Cation Metabolites of Carcinogenic Polycyclic Aromatic Hydrocarbons with DNA. J. Org. Chem. 2007, 72, 4856–4863. [Google Scholar] [CrossRef]
  76. Vongsutilers, V.; Daft, J.R.; Shaughnessy, K.H.; Gannett, P.M. A general synthesis of C8-arylpurine phosphoramidites. Molecules 2009, 14, 3339–3352. [Google Scholar] [CrossRef] [Green Version]
  77. Storr, T.E.; Firth, A.G.; Wilson, K.; Darley, K.; Baumann, C.G.; Fairlamb, I.J.S. Site-selective direct arylation of unprotected adenine nucleosides mediated by palladium and copper: Insights into the reaction mechanism. Tetrahedron 2008, 64, 6125–6137. [Google Scholar] [CrossRef]
  78. Tu, C.; Keane, C.; Eaton, B.E. Palladium Catalysis in the Synthesis of 8-Position modified Adenosine, 2′-Deoxyadenosine and Guanosine. Nucleosides Nucleotides Nucleic Acids 1995, 14, 1631–1638. [Google Scholar] [CrossRef]
  79. Xu, Y.; Ikeda, R.; Sugiyama, H. 8-Methylguanosine: A powerful Z-DNA stabilizer. J. Am. Chem. Soc. 2003, 125, 13519–13524. [Google Scholar] [CrossRef]
  80. Bhanjadeo, M.M.; Subudhi, U. Praseodymium promotes B–Z transition in self-assembled DNA nanostructures. RSC Adv. 2019, 9, 4616–4620. [Google Scholar] [CrossRef] [Green Version]
  81. Feng, L.; Zhao, A.; Ren, J.; Qu, X. Lighting up left-handed Z-DNA: Photoluminescent carbon dots induce DNA B to Z transition and perform DNA logic operations. Nucleic Acids Res. 2013, 41, 7987–7996. [Google Scholar] [CrossRef] [Green Version]
  82. Wu, Z.; Tian, T.; Yu, J.; Weng, X.; Liu, Y.; Zhou, X. Formation of sequence-independent Z-DNA induced by a ruthenium complex at low salt concentrations. Angew. Chem. Int. Ed. Engl. 2011, 50, 11962–11967. [Google Scholar] [CrossRef]
  83. Kim, S.H.; Lim, S.H.; Lee, A.R.; Kwon, D.H.; Song, H.K.; Lee, J.H.; Cho, M.; Johner, A.; Lee, N.K.; Hong, S.C. Unveiling the pathway to Z-DNA in the protein-induced B-Z transition. Nucleic Acids Res. 2018, 46, 4129–4137. [Google Scholar] [CrossRef] [Green Version]
  84. Herbert, A.; Schade, M.; Lowenhaupt, K.; Alfken, J.; Schwartz, T.; Shlyakhtenko, L.S.; Lyubchenko, Y.L.; Rich, A. The Zα domain from human ADAR1 binds to the Z-DNA conformer of many different sequences. Nucleic Acids Res. 1998, 26, 3486–3493. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  85. Sugiyama, H.; Kawai, K.; Matsunaga, A.; Fujimoto, K.; Saito, I.; Robinson, H.; Wang, A.H. Synthesis, structure and thermodynamic properties of 8-methylguanine-containing oligonucleotides: Z-DNA under physiological salt conditions. Nucleic Acids Res. 1996, 24, 1272–1278. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  86. Balasubramaniyam, T.; Ishizuka, T.; Xu, Y. Stability and properties of Z-DNA containing artificial nucleobase 2′-O-methyl-8-methyl guanosine. Bioorgan. Med. Chem. 2019, 27, 364–369. [Google Scholar] [CrossRef] [PubMed]
  87. Balasubramaniyam, T.; Ishizuka, T.; Xiao, C.D.; Bao, H.L.; Xu, Y. Observation of Z-DNA Structure via the Synthesis of Oligonucleotide DNA Containing 8-Trifluoromethyl-2-Deoxyguanosine. Molecules 2018, 23, 2572. [Google Scholar] [CrossRef] [Green Version]
  88. Bao, H.-L.; Masuzawa, T.; Oyoshi, T.; Xu, Y. Oligonucleotides DNA containing 8-trifluoromethyl-2′-deoxyguanosine for observing Z-DNA structure. Nucleic Acids Res. 2020, 48, 7041–7051. [Google Scholar] [CrossRef]
  89. Train, B.C.; Bilgesü, S.A.; Despeaux, E.C.; Vongsutilers, V.; Gannett, P.M. Single C8-Arylguanine modifications render oligonucleotides in the Z-DNA conformation under physiological conditions. Chem. Res. Toxicol. 2014, 27, 1176–1186. [Google Scholar] [CrossRef]
  90. Chen, F.Y.; Park, S.; Otomo, H.; Sakashita, S.; Sugiyama, H. Investigation of B-Z transitions with DNA oligonucleotides containing 8-methylguanine. Artif. DNA PNA XNA 2014, 5, e28226. [Google Scholar] [CrossRef] [Green Version]
  91. Moller, A.; Nordheim, A.; Kozlowski, S.A.; Patel, D.; Rich, A. Bromination stabilizes poly(dG-dC) in the Z-DNA form under low-salt conditions. Biochemistry 1984, 23, 54–62. [Google Scholar] [CrossRef]
  92. Lafer, E.M.; Moller, A.; Nordheim, A.; Stollar, B.D.; Rich, A. Antibodies specific for left-handed Z-DNA. Proc. Natl. Acad. Sci. USA 1981, 78, 3546–3550. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  93. Ross, W.S.; Hardin, C.C.; Tinoco, I., Jr.; Rao, S.N.; Pearlman, D.A.; Kollman, P.A. Effects of nucleotide bromination on the stabilities of Z-RNA and Z-DNA: A molecular mechanics/thermodynamic perturbation study. Biopolymers 1989, 28, 1939–1957. [Google Scholar] [CrossRef]
  94. Suárez-Marina, I.; Abul-Haija, Y.M.; Turk-MacLeod, R.; Gromski, P.S.; Cooper, G.J.T.; Olivé, A.O.; Colón-Santos, S.; Cronin, L. Integrated synthesis of nucleotide and nucleosides influenced by amino acids. Commun. Chem. 2019, 2, 28. [Google Scholar] [CrossRef]
  95. Rayala, R.; Wnuk, S.F. Bromination at C-5 of Pyrimidine and C-8 of Purine Nucleosides with 1,3-Dibromo-5,5-dimethylhydantoin. Tetrahedron Lett. 2012, 53, 3333–3336. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  96. Shapiro, R.; Ellis, S.; Hingerty, B.E.; Broyde, S. Effect of ring size on conformations of aromatic amine-DNA adducts: The aniline-C8 guanine adduct resides in the B-DNA major groove. Chem. Res. Toxicol. 1998, 11, 335–341. [Google Scholar] [CrossRef] [PubMed]
  97. Turesky, R.J.; Markovic, J. DNA adduct formation of the food carcinogen 2-amino-3-methylimidazo[4,5- f]quinoline at the C-8 and N2 atoms of guanine. Chem. Res. Toxicol. 1994, 7, 752–761. [Google Scholar] [CrossRef]
  98. Van Houte, L.P.; Westra, J.G.; Retèl, J.; van Grondelle, R. A spectroscopic study of the conformation of poly d(G-C).poly d(G-C) modified with the carcinogenic 2-aminofluorene. Carcinogenesis 1988, 9, 1017–1027. [Google Scholar] [CrossRef]
  99. Galiègue-Zouitina, S.; Bailleul, B.; Loucheux-Lefebvre, M.H. Guanyl-C8-arylamination of DNA by the ultimate carcinogen of 4-nitroquinoline-1-oxide: A spectrophotometric titration. Anal. Biochem. 1984, 138, 454–457. [Google Scholar] [CrossRef]
  100. Gu, Z.; Gorin, A.; Hingerty, B.E.; Broyde, S.; Patel, D.J. Solution structures of aminofluorene [AF]-stacked conformers of the syn [AF]-C8-dG adduct positioned opposite dC or dA at a template-primer junction. Biochemistry 1999, 38, 10855–10870. [Google Scholar] [CrossRef]
  101. Sharma, P.; Manderville, R.A.; Wetmore, S.D. Modeling the Conformational Preference of the Carbon-Bonded Covalent Adduct Formed upon Exposure of 2′-Deoxyguanosine to Ochratoxin, A. Chem. Res. Toxicol. 2013, 26, 803–816. [Google Scholar] [CrossRef]
  102. Ebert, C.; Simon, N.; Schneider, S.; Carell, T. Structural Insights into the Recognition of N(2) -Aryl- and C8-Aryl DNA Lesions by the Repair Protein XPA/Rad14. Chembiochem 2017, 18, 1379–1382. [Google Scholar] [CrossRef]
  103. Phan, A.T.; Kuryavyi, V.; Luu, K.N.; Patel, D.J. Structure of two intramolecular G-quadruplexes formed by natural human telomere sequences in K+ solution. Nucleic Acids Res. 2007, 35, 6517–6525. [Google Scholar] [CrossRef] [Green Version]
  104. Skolakova, P.; Bednarova, K.; Vorlickova, M.; Sagi, J. Quadruplexes of human telomere dG(3)(TTAG(3))(3) sequences containing guanine abasic sites. Biochem. Biophys. Res. Commun. 2010, 399, 203–208. [Google Scholar] [CrossRef]
  105. Smith, F.W.; Feigon, J. Strand orientation in the DNA quadruplex formed from the Oxytricha telomere repeat oligonucleotide d(G4T4G4) in solution. Biochemistry 1993, 32, 8682–8692. [Google Scholar] [CrossRef]
  106. Tomasko, M.; Vorlickova, M.; Sagi, J. Substitution of adenine for guanine in the quadruplex-forming human telomere DNA sequence G(3)(T(2)AG(3))(3). Biochimie 2009, 91, 171–179. [Google Scholar] [CrossRef]
  107. Xu, Y.; Noguchi, Y.; Sugiyama, H. The new models of the human telomere d[AGGG(TTAGGG)3] in K+ solution. Bioorgan. Med. Chem. 2006, 14, 5584–5591. [Google Scholar] [CrossRef] [PubMed]
  108. Lech, C.J.; Cheow Lim, J.K.; Wen Lim, J.M.; Amrane, S.; Heddi, B.; Phan, A.T. Effects of site-specific guanine C8-modifications on an intramolecular DNA G-quadruplex. Biophys. J. 2011, 101, 1987–1998. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  109. Sagi, J. G-quadruplexes incorporating modified constituents: A review. J. Biomol. Struct. Dyn. 2014, 32, 477–511. [Google Scholar] [CrossRef] [PubMed]
  110. Sannohe, Y.; Sato, K.; Matsugami, A.; Shinohara, K.; Mashimo, T.; Katahira, M.; Sugiyama, H. Orientation of ends of G-quadruplex structure investigated with end-extended oligonucleotides. Nucleic. Acids. Symp. Ser. 2008, 171–172. [Google Scholar] [CrossRef] [Green Version]
  111. Virgilio, A.; Esposito, V.; Randazzo, A.; Mayol, L.; Galeone, A. Effects of 8-methyl-2′-deoxyadenosine incorporation into quadruplex forming oligodeoxyribonucleotides. Bioorgan. Med. Chem. 2005, 13, 1037–1044. [Google Scholar] [CrossRef]
  112. Virgilio, A.; Esposito, V.; Randazzo, A.; Mayol, L.; Galeone, A. 8-methyl-2′-deoxyguanosine incorporation into parallel DNA quadruplex structures. Nucleic Acids Res. 2005, 33, 6188–6195. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  113. Xu, Y.; Sugiyama, H. Formation of the G-quadruplex and i-motif structures in retinoblastoma susceptibility genes (Rb). Nucleic Acids Res. 2006, 34, 949–954. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  114. Dumas, A.; Luedtke, N.W. Cation-Mediated Energy Transfer in G-Quadruplexes Revealed by an Internal Fluorescent Probe. J. Am. Chem. Soc. 2010, 132, 18004–18007. [Google Scholar] [CrossRef] [PubMed]
  115. Esposito, V.; Randazzo, A.; Piccialli, G.; Petraccone, L.; Giancola, C.; Mayol, L. Effects of an 8-bromodeoxyguanosine incorporation on the parallel quadruplex structure [d(TGGGT)]4. Org. Biomol. Chem. 2004, 2, 313–318. [Google Scholar] [CrossRef] [PubMed]
  116. Dias, E.; Battiste, J.L.; Williamson, J.R. Chemical Probe for Glycosidic Conformation in Telomeric DNAs. J. Am. Chem. Soc. 1994, 116, 4479–4480. [Google Scholar] [CrossRef]
  117. Mashimo, T.; Sannohe, Y.; Yagi, H.; Sugiyama, H. Folding pathways of hybrid-1 and hybrid-2 G-quadruplex structures. Nucleic Acids Symp. Ser. 2008, 409–410. [Google Scholar] [CrossRef] [Green Version]
  118. Matsugami, A.; Xu, Y.; Noguchi, Y.; Sugiyama, H.; Katahira, M. Structure of a human telomeric DNA sequence stabilized by 8-bromoguanosine substitutions, as determined by NMR in a K+ solution. FEBS J. 2007, 274, 3545–3556. [Google Scholar] [CrossRef]
  119. Matsugami, A.; Tsuchibayashi, H.; Xu, Y.; Noguchi, Y.; Sugiyama, H.; Katahira, M. The new models of the human telomere DNA in K+ solution revealed by NMR analysis assisted by the incorporation of 8-bromoguanines. Nucleic Acids Symp. Ser. 2006, 45–46. [Google Scholar] [CrossRef] [Green Version]
  120. Gubala, V.; Betancourt, J.E.; Rivera, J.M. Expanding the Hoogsteen Edge of 2′-Deoxyguanosine:  Consequences for G-Quadruplex Formation. Org. Lett. 2004, 6, 4735–4738. [Google Scholar] [CrossRef] [Green Version]
  121. Szalai, V.A.; Singer, M.J.; Thorp, H.H. Site-specific probing of oxidative reactivity and telomerase function using 7,8-dihydro-8-oxoguanine in telomeric DNA. J. Am. Chem. Soc. 2002, 124, 1625–1631. [Google Scholar] [CrossRef]
  122. López de la Osa, J.; González, C.; Gargallo, R.; Rueda, M.; Cubero, E.; Orozco, M.; Aviñó, A.; Eritja, R. Destabilization of quadruplex DNA by 8-aminoguanine. Chembiochem 2006, 7, 46–48. [Google Scholar] [CrossRef]
  123. Dumas, A.; Luedtke, N.W. Highly fluorescent guanosine mimics for folding and energy transfer studies. Nucleic Acids Res. 2011, 39, 6825–6834. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  124. Ben Gaied, N.; Glasser, N.; Ramalanjaona, N.; Beltz, H.; Wolff, P.; Marquet, R.; Burger, A.; Mély, Y. 8-vinyl-deoxyadenosine, an alternative fluorescent nucleoside analog to 2′-deoxyribosyl-2-aminopurine with improved properties. Nucleic Acids Res. 2005, 33, 1031–1039. [Google Scholar] [CrossRef] [Green Version]
  125. Ogasawara, S.; Maeda, M. Photo-controllable aptamer. Nucleic Acids Symp. Ser. 2009, 195–196. [Google Scholar] [CrossRef]
  126. Aschenbrenner, D.; Baumann, F.; Milles, L.F.; Pippig, D.A.; Gaub, H.E. C-5 Propynyl Modifications Enhance the Mechanical Stability of DNA. ChemPhysChem 2015, 16, 2085–2090. [Google Scholar] [CrossRef] [PubMed]
  127. Huang, Y.; Pastor, W.A.; Shen, Y.; Tahiliani, M.; Liu, D.R.; Rao, A. The Behaviour of 5-Hydroxymethylcytosine in Bisulfite Sequencing. PLoS ONE 2010, 5, e8888. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  128. Brown, D.J. 2.13—Pyrimidines and their Benzo Derivatives. In Comprehensive Heterocyclic Chemistry; Katritzky, A.R., Rees, C.W., Eds.; Pergamon: Oxford, UK, 1984; pp. 57–155. [Google Scholar]
  129. Hayakawa, H.; Tanaka, H.; Obi, K.; Itoh, M.; Miyasaka, T. A simple and general entry to 5-substituted uridines based on the regioselective lithiation controlled by a protecting group in the sugar moiety. Tetrahedron Lett. 1987, 28, 87–90. [Google Scholar] [CrossRef]
  130. Tahiliani, M.; Koh, K.P.; Shen, Y.H.; Pastor, W.A.; Bandukwala, H.; Brudno, Y.; Agarwal, S.; Iyer, L.M.; Liu, D.R.; Aravind, L.; et al. Conversion of 5-Methylcytosine to 5-Hydroxymethylcytosine in Mammalian DNA by MLL Partner TET1. Science 2009, 324, 930–935. [Google Scholar] [CrossRef] [Green Version]
  131. Liang, G.; Chan, M.F.; Tomigahara, Y.; Tsai, Y.C.; Gonzales, F.A.; Li, E.; Laird, P.W.; Jones, P.A. Cooperativity between DNA methyltransferases in the maintenance methylation of repetitive elements. Mol. Cell. Biol. 2002, 22, 480–491. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  132. Nagase, H.; Ghosh, S. Epigenetics: Differential DNA methylation in mammalian somatic tissues. FEBS J. 2008, 275, 1617–1623. [Google Scholar] [CrossRef]
  133. Panning, B.; Jaenisch, R. RNA and the Epigenetic Regulation of X Chromosome Inactivation. Cell 1998, 93, 305–308. [Google Scholar] [CrossRef] [Green Version]
  134. Amort, T.; Rieder, D.; Wille, A.; Khokhlova-Cubberley, D.; Riml, C.; Trixl, L.; Jia, X.-Y.; Micura, R.; Lusser, A. Distinct 5-methylcytosine profiles in poly(A) RNA from mouse embryonic stem cells and brain. Genome Biol. 2017, 18, 1. [Google Scholar] [CrossRef] [Green Version]
  135. Fujimoto, K.; Kishi, S.; Sakamoto, T. Geometric effect on the photocrosslinking reaction between 3-cyanovinylcarbazole nucleoside and pyrimidine base in DNA/RNA heteroduplex. Photochem. Photobiol. 2013, 89, 1095–1099. [Google Scholar] [CrossRef]
  136. O’Brown, Z.K.; Boulias, K.; Wang, J.; Wang, S.Y.; O’Brown, N.M.; Hao, Z.; Shibuya, H.; Fady, P.E.; Shi, Y.; He, C.; et al. Sources of artifact in measurements of 6mA and 4mC abundance in eukaryotic genomic DNA. BMC Genom. 2019, 20, 445. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  137. Sharma, V.; Chitranshi, N.; Agarwal, A.K. Significance and biological importance of pyrimidine in the microbial world. Int. J. Med. Chem. 2014, 2014, 202784. [Google Scholar] [CrossRef] [Green Version]
  138. Wescoe, Z.L.; Schreiber, J.; Akeson, M. Nanopores Discriminate among Five C5-Cytosine Variants in DNA. J. Am. Chem. Soc. 2014, 136, 16582–16587. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  139. Bergstrom, D.E.; Ogawa, M.K. C-5 substituted pyrimidine nucleosides. 2. Synthesis via olefin coupling to organopalladium intermediates derived from uridine and 2’-deoxyuridine. J. Am. Chem. Soc. 1978, 100, 8106–8112. [Google Scholar] [CrossRef]
  140. Bradshaw, T.K.; Hutchinson, D.W. 5-Substituted pyrimidine nucleosides and nucleotides. Chem. Soc. Rev. 1977, 6, 43–62. [Google Scholar] [CrossRef]
  141. Bhat, K.S.; Rao, A.S. Synthesis of Uracil, 6-Methyluracil and Some Dihydrouracils. Org. Prep. Proced. Int. 2009, 15, 303–313. [Google Scholar] [CrossRef]
  142. Feng, Z.; Hu, W.; Rom, W.N.; Beland, F.A.; Tang, M.S. N-hydroxy-4-aminobiphenyl-DNA binding in human p53 gene: Sequence preference and the effect of C5 cytosine methylation. Biochemistry 2002, 41, 6414–6421. [Google Scholar] [CrossRef]
  143. Patton, W.; Bacon, V.; Duffield, A.M.; Halpern, B.; Hoyano, Y.; Pereira, W.; Lederberg, J. Chlorination studies. I. The reaction of aqueous hypochlorous acid with cytosine. Biochem. Biophys. Res. Commun. 1972, 48, 880–884. [Google Scholar] [CrossRef]
  144. Su, D.G.; Taylor, J.S.; Gross, M.L. A new photoproduct of 5-methylcytosine and adenine characterized by high-performance liquid chromatography and mass spectrometry. Chem. Res. Toxicol. 2010, 23, 474–479. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  145. Zhu, S.; Ren, L.; Wang, J.; Zheng, G.; Tang, P. Two-step efficient synthesis of 5-methyluridine via two thermostable nucleoside phosphorylase from Aeropyrum pernix. Bioorgan. Med. Chem. Lett. 2012, 22, 2102–2104. [Google Scholar] [CrossRef] [PubMed]
  146. Sasnauskas, G.; Zagorskaite, E.; Kauneckaite, K.; Tamulaitiene, G.; Siksnys, V. Structure-guided sequence specificity engineering of the modification-dependent restriction endonuclease LpnPI. Nucleic Acids Res. 2015, 43, 6144–6155. [Google Scholar] [CrossRef] [Green Version]
  147. Wang, G.; Dyatkina, N.; Prhavc, M.; Williams, C.; Serebryany, V.; Hu, Y.; Huang, Y.; Wan, J.; Wu, X.; Deval, J.; et al. Synthesis and Anti-HCV Activities of 4′-Fluoro-2′-Substituted Uridine Triphosphates and Nucleotide Prodrugs: Discovery of 4′-Fluoro-2′- C-methyluridine 5′-Phosphoramidate Prodrug (AL-335) for the Treatment of Hepatitis C Infection. J. Med. Chem. 2019, 62, 4555–4570. [Google Scholar] [CrossRef] [PubMed]
  148. Sharma, V.K.; Sharma, R.K.; Singh, S.K. Antisense oligonucleotides: Modifications and clinical trials. MedChemComm 2014, 5, 1454–1471. [Google Scholar] [CrossRef]
  149. Østergaard, M.E.; Kumar, P.; Baral, B.; Guenther, D.C.; Anderson, B.A.; Ytreberg, F.M.; Deobald, L.; Paszczynski, A.J.; Sharma, P.K.; Hrdlicka, P.J. C5-functionalized DNA, LNA, and α-L-LNA: Positional control of polarity-sensitive fluorophores leads to improved SNP-typing. Chemistry 2011, 17, 3157–3165. [Google Scholar] [CrossRef]
  150. Wolk, S.K.; Mayfield, W.S.; Gelinas, A.D.; Astling, D.; Guillot, J.; Brody, E.N.; Janjic, N.; Gold, L. Modified nucleotides may have enhanced early RNA catalysis. Proc. Natl. Acad. Sci. USA 2020, 117, 8236–8242. [Google Scholar] [CrossRef] [PubMed]
  151. Russo, A.; Gianni, L.; Kinsella, T.J.; Klecker, R.W., Jr.; Jenkins, J.; Rowland, J.; Glatstein, E.; Mitchell, J.B.; Collins, J.; Myers, C. Pharmacological evaluation of intravenous delivery of 5-bromodeoxyuridine to patients with brain tumors. Cancer Res. 1984, 44, 1702–1705. [Google Scholar] [PubMed]
  152. Kofoed, R.H.; Betzer, C.; Lykke-Andersen, S.; Molska, E.; Jensen, P.H. Investigation of RNA Synthesis Using 5-Bromouridine Labelling and Immunoprecipitation. JoVE 2018, e57056. [Google Scholar] [CrossRef] [Green Version]
  153. Ochoa, S.; Milam, V.T. Modified Nucleic Acids: Expanding the Capabilities of Functional Oligonucleotides. Molecules 2020, 25, 4659. [Google Scholar] [CrossRef]
  154. Held, H.A.; Roychowdhury, A.; Benner, S.A. C-5 modified nucleosides: Direct insertion of alkynyl-thio functionality in pyrimidines. Nucleosides Nucleotides Nucleic Acids 2003, 22, 391–404. [Google Scholar] [CrossRef]
  155. Yang, Q.; Wei, T.; He, Y.; Liang, Y.; Zhang, Z.-T. Direct Arylation of 5-Iodouracil and 5-Iodouridine with Heteroarenes and BenzeneviaPhotochemical Reaction. Helv. Chim. Acta 2015, 98, 953–960. [Google Scholar] [CrossRef]
  156. Hwang, C.H.; Park, J.S.; Won, J.H.; Kim, J.N.; Ryu, E.K. The oxidative iodination of pyrimidine bases and their nucleosides using iodine/dimethylformamide/ m-chloroperbenzoic acid. Arch. Pharmacal Res. 1992, 15, 69–72. [Google Scholar] [CrossRef]
  157. Itahara, T.; Ide, N. Myeloperoxidase Catalyzed Bromination of Nucleic Acid Bases and Related Compounds. Bull. Chem. Soc. Jpn. 1989, 62, 3750–3751. [Google Scholar] [CrossRef] [Green Version]
  158. Ito, Y.; Masaki, Y.; Kanamori, T.; Ohkubo, A.; Seio, K.; Sekine, M. Synthesis of 5-[3-(2-aminopyrimidin-4-yl)aminopropyn-1-yl]uracil derivative that recognizes Ade-Thy base pairs in double-stranded DNA. Bioorgan. Med. Chem. Lett. 2016, 26, 194–196. [Google Scholar] [CrossRef]
  159. Ashwell, M.; Jones, A.S.; Kumar, A.; Sayers, J.R.; Walker, R.T.; Sakuma, T.; De Clercq, E. The synthesis and antiviral properties of ()-5-(2-bromovinyl)-2’-deoxyuridine-related compounds. Tetrahedron 1987, 43, 4601–4608. [Google Scholar] [CrossRef]
  160. Liang, Y.; Wnuk, S.F. Modification of purine and pyrimidine nucleosides by direct C-H bond activation. Molecules 2015, 20, 4874–4901. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  161. Liang, Y.; Gloudeman, J.; Wnuk, S.F. Palladium-Catalyzed Direct Arylation of 5-Halouracils and 5-Halouracil Nucleosides with Arenes and Heteroarenes Promoted by TBAF. J. Org. Chem. 2014, 79, 4094–4103. [Google Scholar] [CrossRef] [PubMed]
  162. Ruth, J.L.; Bergstrom, D.E. C-5 substituted pyrimidine nucleosides. 1. Synthesis of C-5 allyl, propyl, and propenyl uracil and cytosine nucleosides via organopalladium intermediates. J. Org. Chem. 1978, 43, 2870–2876. [Google Scholar] [CrossRef]
  163. Robins, M.J.; Barr, P.J. Nucleic acid related compounds. 39. Efficient conversion of 5-iodo to 5-alkynyl and derived 5-substituted uracil bases and nucleosides. J. Org. Chem. 1983, 48, 1854–1862. [Google Scholar] [CrossRef]
  164. Western, E.C.; Daft, J.R.; Johnson, E.M.; Gannett, P.M.; Shaughnessy, K.H. Efficient One-Step Suzuki Arylation of Unprotected Halonucleosides, Using Water-Soluble Palladium Catalysts. J. Org. Chem. 2003, 68, 6767–6774. [Google Scholar] [CrossRef]
  165. Fresneau, N.; Hiebel, M.-A.; Agrofoglio, L.A.; Berteina-Raboin, S. Efficient Synthesis of Unprotected C-5-Aryl/Heteroaryl-2’-deoxyuridine via a Suzuki-Miyaura Reaction in Aqueous Media. Molecules 2012, 17, 14409–14417. [Google Scholar] [CrossRef] [Green Version]
  166. Gutierrez, A.J.; Terhorst, T.J.; Matteucci, M.D.; Froehler, B.C. 5-Heteroaryl-2′-deoxyuridine Analogs. Synthesis and Incorporation into High-Affinity Oligonucleotides. J. Am. Chem. Soc. 1994, 116, 5540–5544. [Google Scholar] [CrossRef]
  167. Peyron, C.; Benhida, R.; Bories, C.; Loiseau, P.M. Synthesis and in vitro antileishmanial activity of 5-substituted-2’-deoxyuridine derivatives. Bioorgan. Chem. 2005, 33, 439–447. [Google Scholar] [CrossRef]
  168. Tian, M.; Yu, M.; Shi, T.; Hu, J.; Li, S.; Xu, J.; Chen, N.; Du, H. Silver-Catalyzed Direct C6-H Arylation of Purines and Purine Nucleosides with Arylboronic Acids. Eur. J. Org. Chem. 2017, 2017, 3415–3420. [Google Scholar] [CrossRef]
  169. Gayakhe, V.; Sanghvi, Y.S.; Fairlamb, I.J.; Kapdi, A.R. Catalytic C-H bond functionalisation of purine and pyrimidine nucleosides: A synthetic and mechanistic perspective. Chem. Commun. 2015, 51, 11944–11960. [Google Scholar] [CrossRef] [PubMed]
  170. Čerňová, M.; Čerňa, I.; Pohl, R.; Hocek, M. Regioselective Direct C–H Arylations of Protected Uracils. Synthesis of 5- and 6-Aryluracil Bases. J. Org. Chem. 2011, 76, 5309–5319. [Google Scholar] [CrossRef] [PubMed]
  171. Sahnoun, S.; Messaoudi, S.; Peyrat, J.F.; Brion, J.D.; Alami, M. Microwave-assisted Pd(OH)(2)-catalyzed direct C-H arylation of free-(NH2) adenines with aryl halides. Tetrahedron Lett. 2008, 49, 7279–7283. [Google Scholar] [CrossRef]
  172. Mori, Y.; Seki, M. Pd(OH)2/C (Pearlman’s Catalyst):  A Highly Active Catalyst for Fukuyama, Sonogashira, and Suzuki Coupling Reactions. J. Org. Chem. 2003, 68, 1571–1574. [Google Scholar] [CrossRef] [PubMed]
  173. Fu, H.Y.; Chen, L.; Doucet, H. Phosphine-Free Palladium-Catalyzed Direct Arylation of Imidazo[1,2-a]pyridines with Aryl Bromides at Low Catalyst Loading. J. Org. Chem. 2012, 77, 4473–4478. [Google Scholar] [CrossRef]
  174. Fuertes, M.A.; Cepeda, V.; Alonso, C.; Perez, J.M. Molecular mechanisms for the B-Z transition in the example of poly[d(G-C) x d(G-C)] polymers. A critical review. Chem. Rev. 2006, 106, 2045–2064. [Google Scholar] [CrossRef] [PubMed]
  175. Behe, M.; Felsenfeld, G. Effects of methylation on a synthetic polynucleotide: The B–Z transition in poly(dG-m5dC).poly(dG-m5dC). Proc. Natl. Acad. Sci. USA 1981, 78, 1619–1623. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  176. Sheardy, R.D.; Levine, N.; Marotta, S.; Suh, D.; Chaires, J.B. A thermodynamic investigation of the melting of B-Z junction forming DNA oligomers. Biochemistry 1994, 33, 1385–1391. [Google Scholar] [CrossRef]
  177. Taboury, J.A.; Adam, S.; Taillandier, E.; Neumann, J.M.; Tran-Dinh, S.; Huynh-Dinh, T.; Langlois d’Estaintot, B.; Conti, M.; Igolen, J. The B–Z transition in two synthetic oligonucleotides: D(C-2-amino-ACGTG) and d(m5CGCAm5CGTGCG) studied by IR, NMR and CD spectroscopies. Nucleic Acids Res. 1984, 12, 6291–6305. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  178. Rich, A.; Nordheim, A.; Wang, A.H. The chemistry and biology of left-handed Z-DNA. Annu. Rev. Biochem. 1984, 53, 791–846. [Google Scholar] [CrossRef]
  179. Herbert, A. ALU non-B-DNA conformations, flipons, binary codes and evolution. R. Soc. Open Sci. 2020, 7, 200222. [Google Scholar] [CrossRef]
  180. Vongsutilers, V.; Shinohara, Y.; Kawai, G. Epigenetic TET-Catalyzed Oxidative Products of 5-Methylcytosine Impede Z-DNA Formation of CG Decamers. ACS Omega 2020, 5, 8056–8064. [Google Scholar] [CrossRef]
  181. Wang, S.; Long, Y.; Wang, J.; Ge, Y.; Guo, P.; Liu, Y.; Tian, T.; Zhou, X. Systematic investigations of different cytosine modifications on CpG dinucleotide sequences: The effects on the B-Z transition. J. Am. Chem. Soc. 2014, 136, 56–59. [Google Scholar] [CrossRef]
  182. Wang, J.; Wang, S.; Zhong, C.; Tian, T.; Zhou, X. Novel insights into a major DNA oxidative lesion: Its effects on Z-DNA stabilization. Org. Biomol. Chem. 2015, 13, 8996–8999. [Google Scholar] [CrossRef] [PubMed]
  183. Yang, T.; Low, J.J.A.; Woon, E.C.Y. A general strategy exploiting m5C duplex-remodelling effect for selective detection of RNA and DNA m5C methyltransferase activity in cells. Nucleic Acids Res. 2020, 48, e5. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  184. Kagawa, T.F.; Howell, M.L.; Tseng, K.; Ho, P.S. Effects of base substituents on the hydration of B- and Z-DNA: Correlations to the B- to Z-DNA transition. Nucleic Acids Res. 1993, 21, 5978–5986. [Google Scholar] [CrossRef] [Green Version]
  185. Fujii, S.; Wang, A.H.; van der Marel, G.; van Boom, J.H.; Rich, A. Molecular structure of (m5 dC-dG)3: The role of the methyl group on 5-methyl cytosine in stabilizing Z-DNA. Nucleic Acids Res. 1982, 10, 7879–7892. [Google Scholar] [CrossRef] [Green Version]
  186. Popenda, M.; Milecki, J.; Adamiak, R.W. High salt solution structure of a left-handed RNA double helix. Nucleic Acids Res. 2004, 32, 4044–4054. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  187. Temiz, N.A.; Donohue, D.E.; Bacolla, A.; Luke, B.T.; Collins, J.R. The role of methylation in the intrinsic dynamics of B- and Z-DNA. PLoS ONE 2012, 7, e35558. [Google Scholar] [CrossRef]
  188. Belmont, P.; Constant, J.F.; Demeunynck, M. Nucleic acid conformation diversity: From structure to function and regulation. Chem. Soc. Rev. 2001, 30, 70–81. [Google Scholar] [CrossRef]
  189. Herbert, A.G.; Rich, A. A method to identify and characterize Z-DNA binding proteins using a linear oligodeoxynucleotide. Nucleic Acids Res. 1993, 21, 2669–2672. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  190. Gislason, K.; Sigurdsson, S.T. Synthesis of a 5’-6-Locked, 1,10-Phenanthroline-Containing Nucleoside and Its Incorporation into DNA. Eur. J. Org. Chem. 2010, 2010, 4713–4718. [Google Scholar] [CrossRef]
  191. Hardin, C.C.; Zarling, D.A.; Puglisi, J.D.; Trulson, M.O.; Davis, P.W.; Tinoco, I., Jr. Stabilization of Z-RNA by chemical bromination and its recognition by anti-Z-DNA antibodies. Biochemistry 1987, 26, 5191–5199. [Google Scholar] [CrossRef]
  192. Mukherjee, A.K.; Sharma, S.; Chowdhury, S. Non-duplex G-Quadruplex Structures Emerge as Mediators of Epigenetic Modifications. Trends Genet. 2019, 35, 129–144. [Google Scholar] [CrossRef] [Green Version]
  193. Lin, J.; Hou, J.Q.; Xiang, H.D.; Yan, Y.Y.; Gu, Y.C.; Tan, J.H.; Li, D.; Gu, L.Q.; Ou, T.M.; Huang, Z.S. Stabilization of G-quadruplex DNA by C-5-methyl-cytosine in bcl-2 promoter: Implications for epigenetic regulation. Biochem. Biophys. Res. Commun. 2013, 433, 368–373. [Google Scholar] [CrossRef]
  194. Hardin, C.C.; Corregan, M.; Brown, B.A., 2nd; Frederick, L.N. Cytosine-cytosine+ base pairing stabilizes DNA quadruplexes and cytosine methylation greatly enhances the effect. Biochemistry 1993, 32, 5870–5880. [Google Scholar] [CrossRef]
  195. Xu, Y.; Sugiyama, H. Highly Efficient Photochemical 2′-Deoxyribonolactone Formation at the Diagonal Loop of a 5-Iodouracil-Containing Antiparallel G-Quartet. J. Am. Chem. Soc. 2004, 126, 6274–6279. [Google Scholar] [CrossRef]
  196. Li, Y.; Sugiyama, H. Photoreactivity of the linker region of two consecutive G-quadruplexes formed by human telomeric DNA. Chem. Comm. 2015, 51, 8861–8864. [Google Scholar] [CrossRef] [Green Version]
  197. Heinen, L.; Walther, A. Temporal control of i-motif switch lifetimes for autonomous operation of transient DNA nanostructures. Chem. Sci. 2017, 8, 4100–4107. [Google Scholar] [CrossRef] [Green Version]
  198. Gueron, M.; Leroy, J.L. The i-motif in nucleic acids. Curr. Opin. Struct. Biol. 2000, 10, 326–331. [Google Scholar] [CrossRef]
  199. Bielecka, P.; Dembska, A.; Juskowiak, B. Monitoring of pH Using an i-Motif-Forming Sequence Containing a Fluorescent Cytosine Analogue, tC. Molecules 2019, 24, 952. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  200. Bhavsar-Jog, Y.P.; Van Dornshuld, E.; Brooks, T.A.; Tschumper, G.S.; Wadkins, R.M. Epigenetic modification, dehydration, and molecular crowding effects on the thermodynamics of i-motif structure formation from C-rich DNA. Biochemistry 2014, 53, 1586–1594. [Google Scholar] [CrossRef] [PubMed]
  201. Abou Assi, H.; Garavís, M.; González, C.; Damha, M.J. i-Motif DNA: Structural features and significance to cell biology. Nucleic Acids Res. 2018, 46, 8038–8056. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  202. Wright, E.P.; Lamparska, K.; Smith, S.S.; Waller, Z.A.E. Substitution of Cytosine with Guanylurea Decreases the Stability of i-Motif DNA. Biochemistry 2017, 56, 4879–4883. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  203. Lannes, L.; Halder, S.; Krishnan, Y.; Schwalbe, H. Tuning the pH Response of i-Motif DNA Oligonucleotides. Chembiochem 2015, 16, 1647–1656. [Google Scholar] [CrossRef] [PubMed]
  204. Wright, E.P.; Abdelhamid, M.A.S.; Ehiabor, M.O.; Grigg, M.C.; Irving, K.; Smith, N.M.; Waller, Z.A.E. Epigenetic modification of cytosines fine tunes the stability of i-motif DNA. Nucleic Acids Res. 2020, 48, 55–62. [Google Scholar] [CrossRef] [PubMed]
  205. Xu, B.; Devi, G.; Shao, F. Regulation of telomeric i-motif stability by 5-methylcytosine and 5-hydroxymethylcytosine modification. Org. Biomol. Chem. 2015, 13, 5646–5651. [Google Scholar] [CrossRef] [PubMed]
  206. Benabou, S.; Aviñó, A.; Eritja, R.; González, C.; Gargallo, R. Fundamental aspects of the nucleic acid i-motif structures. RSC Adv. 2014, 4, 26956–26980. [Google Scholar] [CrossRef] [Green Version]
  207. Han, X.; Leroy, J.L.; Gueron, M. An intramolecular i-motif: The solution structure and base-pair opening kinetics of d(5mCCT3CCT3ACCT3CC). J. Mol. Biol. 1998, 278, 949–965. [Google Scholar] [CrossRef]
  208. Phan, A.T.; Gueron, M.; Leroy, J.L. The solution structure and internal motions of a fragment of the cytidine-rich strand of the human telomere. J. Mol. Biol. 2000, 299, 123–144. [Google Scholar] [CrossRef]
  209. Kendrick, S.; Akiyama, Y.; Hecht, S.M.; Hurley, L.H. The i-motif in the bcl-2 P1 promoter forms an unexpectedly stable structure with a unique 8:5:7 loop folding pattern. J. Am. Chem. Soc. 2009, 131, 17667–17676. [Google Scholar] [CrossRef] [Green Version]
  210. Yang, B.; Rodgers, M.T. Base-Pairing Energies of Protonated Nucleoside Base Pairs of dCyd and m(5)dCyd: Implications for the Stability of DNA i-Motif Conformations. J. Am. Soc. Mass Spectrom. 2015, 26, 1394–1403. [Google Scholar] [CrossRef] [Green Version]
  211. Assi, H.A.; Harkness, R.W.; Martin-Pintado, N.; Wilds, C.J.; Campos-Olivas, R.; Mittermaier, A.K.; Gonzalez, C.; Damha, M.J. Stabilization of i-motif structures by 2’-beta-fluorination of DNA. Nucleic Acids Res. 2016, 44, 4998–5009. [Google Scholar] [CrossRef] [Green Version]
  212. Osborne, S.D.; Powers, V.E.; Rusling, D.A.; Lack, O.; Fox, K.R.; Brown, T. Selectivity and affinity of triplex-forming oligonucleotides containing 2’-aminoethoxy-5-(3-aminoprop-1-ynyl)uridine for recognizing AT base pairs in duplex DNA. Nucleic Acids Res. 2004, 32, 4439–4447. [Google Scholar] [CrossRef]
  213. Frank-Kamenetskii, M.D.; Mirkin, S.M. Triplex DNA structures. Annu. Rev. Biochem. 1995, 64, 65–95. [Google Scholar] [CrossRef]
  214. Kumar, P.; Sharma, P.K.; Hansen, J.; Jedinak, L.; Reslow-Jacobsen, C.; Hornum, M.; Nielsen, P. Three new double-headed nucleotides with additional nucleobases connected to C-5 of pyrimidines; synthesis, duplex and triplex studies. Bioorgan. Med. Chem. 2016, 24, 742–749. [Google Scholar] [CrossRef]
  215. Brazier, J.A.; Shibata, T.; Townsley, J.; Taylor, B.F.; Frary, E.; Williams, N.H.; Williams, D.M. Amino-functionalized DNA: The properties of C5-amino-alkyl substituted 2’-deoxyuridines and their application in DNA triplex formation. Nucleic Acids Res. 2005, 33, 1362–1371. [Google Scholar] [CrossRef] [Green Version]
  216. Kanamori, T.; Masaki, Y.; Mizuta, M.; Tsunoda, H.; Ohkubo, A.; Sekine, M.; Seio, K. DNA duplexes and triplex-forming oligodeoxynucleotides incorporating modified nucleosides forming stable and selective triplexes. Org. Biomol. Chem. 2012, 10, 1007–1013. [Google Scholar] [CrossRef]
  217. Rusling, D.A.; Peng, G.; Srinivasan, N.; Fox, K.R.; Brown, T. DNA triplex formation with 5-dimethylaminopropargyl deoxyuridine. Nucleic Acids Res. 2009, 37, 1288–1296. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  218. Sau, S.P.; Kumar, P.; Anderson, B.A.; Ostergaard, M.E.; Deobald, L.; Paszczynski, A.; Sharma, P.K.; Hrdlicka, P.J. Optimized DNA-targeting using triplex forming C5-alkynyl functionalized LNA. Chem. Commun. 2009, 6756–6758. [Google Scholar] [CrossRef]
  219. Devi, G.; Zhou, Y.; Zhong, Z.; Toh, D.F.; Chen, G. RNA triplexes: From structural principles to biological and biotech applications. Wiley Interdiscip. Rev. RNA 2015, 6, 111–128. [Google Scholar] [CrossRef] [PubMed]
  220. Duca, M.; Vekhoff, P.; Oussedik, K.; Halby, L.; Arimondo, P.B. The triple helix: 50 years later, the outcome. Nucleic Acids Res. 2008, 36, 5123–5138. [Google Scholar] [CrossRef] [PubMed]
  221. McKinney, J.A.; Wang, G.; Mukherjee, A.; Christensen, L.; Subramanian, S.H.S.; Zhao, J.; Vasquez, K.M. Distinct DNA repair pathways cause genomic instability at alternative DNA structures. Nat. Commun. 2020, 11, 236. [Google Scholar] [CrossRef] [Green Version]
  222. Sipa, K.; Sochacka, E.; Kazmierczak-Baranska, J.; Maszewska, M.; Janicka, M.; Nowak, G.; Nawrot, B. Effect of base modifications on structure, thermodynamic stability, and gene silencing activity of short interfering RNA. RNA 2007, 13, 1301–1316. [Google Scholar] [CrossRef] [PubMed] [Green Version]
Figure 1. The organic structural formulas for the bases in nucleic acids, DNA and RNA. The numbering of elements in the molecules is indicated by red color.
Figure 1. The organic structural formulas for the bases in nucleic acids, DNA and RNA. The numbering of elements in the molecules is indicated by red color.
Ijms 22 09552 g001
Figure 2. Methylations of purines: (a) 8-methylguanosines and (b) 8-methyladenosines. Bromide and methyl groups are highlighted.
Figure 2. Methylations of purines: (a) 8-methylguanosines and (b) 8-methyladenosines. Bromide and methyl groups are highlighted.
Ijms 22 09552 g002
Figure 3. Typical brominations of purines: (a) 8-bromoguanosines and (b) 8-bromoadenosines with N-bromosuccinimide (NBS).
Figure 3. Typical brominations of purines: (a) 8-bromoguanosines and (b) 8-bromoadenosines with N-bromosuccinimide (NBS).
Ijms 22 09552 g003
Figure 4. (a) Typical synthesis of 8-arylated guanosine. (b) Scheme for direct arylated guanosine derivatives at the C8 position.
Figure 4. (a) Typical synthesis of 8-arylated guanosine. (b) Scheme for direct arylated guanosine derivatives at the C8 position.
Ijms 22 09552 g004
Figure 5. Purines substrates (1: guanine, 2: 2’-deoxy guanosine, 3: 2’-ribose adenosine, and 4: 3’,5’-di-O-acetyl-2’-deoxy adenosine) are involved in the acylation employed by palladium catalyst.
Figure 5. Purines substrates (1: guanine, 2: 2’-deoxy guanosine, 3: 2’-ribose adenosine, and 4: 3’,5’-di-O-acetyl-2’-deoxy adenosine) are involved in the acylation employed by palladium catalyst.
Ijms 22 09552 g005
Figure 7. Carcinogenic adducts guanosine derivatives at the C8 position: (a) (I) The AAF and (II) AF; (b) Ochratoxin A and 8-OTA dG; (c) 8-oxo G; (d) 8-arylated compound at the C8 position, 8-aminoguanine (n8G), 8-(2-pyridyl)guanine (2PyG), 8-(2-phenylethenyl)-dG and 8-[2-(pyrid-4-yl)- ethenyl]-dG and 8-fluorenylvinyl-dG (Fv8G), respectively.
Figure 7. Carcinogenic adducts guanosine derivatives at the C8 position: (a) (I) The AAF and (II) AF; (b) Ochratoxin A and 8-OTA dG; (c) 8-oxo G; (d) 8-arylated compound at the C8 position, 8-aminoguanine (n8G), 8-(2-pyridyl)guanine (2PyG), 8-(2-phenylethenyl)-dG and 8-[2-(pyrid-4-yl)- ethenyl]-dG and 8-fluorenylvinyl-dG (Fv8G), respectively.
Ijms 22 09552 g007
Figure 8. (a) Graphical representation of 8-methylguanosine and 8-arylated guanosine; (b) stabilized anti-parallel structures of G-quadruplexes in K+ solution; (c) CD spectra of G-quadruplex sequence, which contains 8-methyl guanosine: ([d(TGGGT)]2) at 20 °C (dotted), Q1 at 20 °C (solid), Q2 at 20 °C (dashed), and Q3 at 5 °C (dashed dot); (d) CD spectra of ORN-1 (UA(8BrrG)GGU, red solid line, parallel G4 structure), ORN2 (UAG(8BrrG)GU, green solid line, anti-parallel G4 structure), and ORN3 (UAGG(8BrrG)U, black solid line, single-strand structure). Copyright (2017) Springer Nature, and (2005) Oxford University Press.
Figure 8. (a) Graphical representation of 8-methylguanosine and 8-arylated guanosine; (b) stabilized anti-parallel structures of G-quadruplexes in K+ solution; (c) CD spectra of G-quadruplex sequence, which contains 8-methyl guanosine: ([d(TGGGT)]2) at 20 °C (dotted), Q1 at 20 °C (solid), Q2 at 20 °C (dashed), and Q3 at 5 °C (dashed dot); (d) CD spectra of ORN-1 (UA(8BrrG)GGU, red solid line, parallel G4 structure), ORN2 (UAG(8BrrG)GU, green solid line, anti-parallel G4 structure), and ORN3 (UAGG(8BrrG)U, black solid line, single-strand structure). Copyright (2017) Springer Nature, and (2005) Oxford University Press.
Ijms 22 09552 g008
Figure 9. (a) Typical synthesis of 5-arylated cytosine. (b) Scheme for direct arylated uracil derivatives at the C5 position.
Figure 9. (a) Typical synthesis of 5-arylated cytosine. (b) Scheme for direct arylated uracil derivatives at the C5 position.
Ijms 22 09552 g009
Figure 10. (a) Graphical representation of modified cytosine and uracil at the C5 position; (b) structures of i-motif and Triplex; (c) CD spectra of i-motif-containing modified cytosine at different pH indicated by different colors, from ref. [203]; (d) comparison of CD spectra between duplex (solid), triplex (dashed dot), and triplex-forming oligonucleotides (TFO, dashed) containing modified sequence at pH 6 from ref. [212]. Copyright (2015) John Wiley and Sons, Inc., and (2004) Oxford University.
Figure 10. (a) Graphical representation of modified cytosine and uracil at the C5 position; (b) structures of i-motif and Triplex; (c) CD spectra of i-motif-containing modified cytosine at different pH indicated by different colors, from ref. [203]; (d) comparison of CD spectra between duplex (solid), triplex (dashed dot), and triplex-forming oligonucleotides (TFO, dashed) containing modified sequence at pH 6 from ref. [212]. Copyright (2015) John Wiley and Sons, Inc., and (2004) Oxford University.
Ijms 22 09552 g010
Table 1. Palladium (Pd) mediated the direct arylation at the C8 position of various purine derivatives. The structures of substrates are described in Figure 5.
Table 1. Palladium (Pd) mediated the direct arylation at the C8 position of various purine derivatives. The structures of substrates are described in Figure 5.
SubstrateEntryBase/Ligand
and Solvent
Temp (°C)ArylYield (%)Reference
11NaCO3/TPPTS
DMSO
90 °C Ijms 22 09552 i00191%[75]
22NaCO3/TPPTS
H2O
80 °C Ijms 22 09552 i00285%[76]
3NaCO3/TPPTS
H2O
80 °C67%
4NaCO3/TPPTS
H2O
80 °C83%
5NaCO3/TPPTS
H2O
80 °C83%
6NaCO3/TPPTS
H2O
80 °C72%
37CuI/piperidine
DMF
150 °C Ijms 22 09552 i00355%[62]
8CuI/piperidine
DMF
150 °C68%
9CuI/piperidine
DMF
150 °C55%
10Cs2CO3/CuI
DMF
120 °C66%[77]
411CuI/PPh3
THF
90 °C Ijms 22 09552 i00495%[78]
Substrates are described in Figure 5.
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Balasubramaniyam, T.; Oh, K.-I.; Jin, H.-S.; Ahn, H.-B.; Kim, B.-S.; Lee, J.-H. Non-Canonical Helical Structure of Nucleic Acids Containing Base-Modified Nucleotides. Int. J. Mol. Sci. 2021, 22, 9552. https://doi.org/10.3390/ijms22179552

AMA Style

Balasubramaniyam T, Oh K-I, Jin H-S, Ahn H-B, Kim B-S, Lee J-H. Non-Canonical Helical Structure of Nucleic Acids Containing Base-Modified Nucleotides. International Journal of Molecular Sciences. 2021; 22(17):9552. https://doi.org/10.3390/ijms22179552

Chicago/Turabian Style

Balasubramaniyam, Thananjeyan, Kwnag-Im Oh, Ho-Seong Jin, Hye-Bin Ahn, Byeong-Seon Kim, and Joon-Hwa Lee. 2021. "Non-Canonical Helical Structure of Nucleic Acids Containing Base-Modified Nucleotides" International Journal of Molecular Sciences 22, no. 17: 9552. https://doi.org/10.3390/ijms22179552

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop